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The objective of this thesis is the establishment of the systematic design of the
interaction between the different vesicles membrane based on the key properties of the
membrane. The interest is focused on (1) characteization of key parameters of
surfactant vesicles, (2) analysis of the interaction between detergent vesicle and lipid
vesicle, and (3) possible application to control of the membrane-related phenomena
(such as drug-delivery system).
The author hopes that this research could contribute to the rational design of
the novel drug carrier in drug delivery system, together with the deeper understanding
of all phenomenon relating to the membrane.
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Summary
Surfactant molecules can form avaiety of self assembles in an aqueous environment. The vesicle
membrane is known to induce various kinds of unique properties (membrane properties), which
differs from those of the single molecule.. Howeveg a clear relationship between membrane
properties and membrane behaviors (i.e. aggregation, fusion, and interaction with molecule) has not
been clarified yet. In this thesis, the method to charactenze the membrane properties was established
through the systematic investigation of various properties in addition to the conventionally-used
property (membrane fluidity). Various kinds of surfactant vesicles were categorized according to the
obtained membrane properties. Based on the relationship between membrane properties and
"membrane-membrane" interaction, the method to control the interaction of different surfactant
vesicles was finally presented.
In chapter 1, the surfactant vesicle (liposome or Span 80 vesicle) was analyzed by using various
fluorescence probes (DPH, TMA-DPH, Laurdan, and ANS) and by using dielectric dispersion
analysis. Both interior and surface of the surfactant vesicle membrane were systematically
characterized, especially focusing on three kinds of properties, such as "Fluit' (membrane fluidity),
*Flexible" (headgroup mobility) and o'Wet" (membrane polarity). The interior property of Span 80
vesicle was similar to that of liposome, while there is a difference in the surface property. The
dielectric dispersion analysis revealed the high intense headgroup mobility of Span 80 vesicle as
compared with liposome. This property was also found to affect the insertion of water molecules into
the Span 80 vesicle membrane.
In chapter 2, the interaction between different vesicles was investigated based on their membrane
properties. Span 80 vesicle with intense headgroup mobility could easily interact with liposome,
resulting in the perturbation of liposomal membrane. The perturbation effect was dependent on the
membrane properties of liposome. Phospholipids at gel phase are tightly anayed on the membrane,
resulting in the intense perturbation after the insertion of Span 80 vesicle into the liposome
membrane. The above results show that the liposome membrane cannot be reconstructed after the
fusion of Span 80 vesicle owing to the incompatibility of phase state between two vesicles. In
addition, the membrane penetration of doxorubicin hydrochloride was also found to be dependent on
the membrane polarity. These results show that the characteized membrane properties can
contribute to the understanding of 'omembrane-membrane" interaction.
In chapter 3, a design scheme for the efficient drug delivery was finally proposed based on the
above findings. The headgroup mobility was first studied as the first step of interaction between
surfactant vesicle and plasma membrane. Span 80 vesicle with high headgroup mobility could
effectively deliver the drug to cells as compared with liposome. After the fusion with plasma
membrane, Span 80 vesicle with high fluidity diffi.rses immediately on the plasma membrane. The
plasma membrane fused with Span 80 vesicle resulted in the induction of the apoptotic like cell death
(blebbing, and exposure of phosphatidylserine). On the other hand, it has been shown that hybrid
vesicle (vesicle-in-vesicle system) can deriver the inner second vesicle into the cytoplasm. Moreover,
the accumulation of drug into the cells was improved by modifying the surfactant vesicle with
protein targeting a cancer cell.
As a whole, it has been shown that the "membrane-membrane" interaction between different
vesicles can be controlled based on the characteized membrane properties by using the method
presented in this thesis. It is expected that the clarified relationship between membrane properties
and "membrane-membrane" interaction can contribute not only to the design of effective drug carrier,
but also to the understanding of phenomenon on/in the membrane.
General Introduction
Surfactant molecule that has both hydrophobic and hydrophilic groups in its
structure can form various kinds of "self-assembly'' structures in aqueous or organic
environment, such as micelle, disc, hexagonal cylinder, and vesicle (Fig. 1). The
conformation of the self-assemble is also known to be related with the structure of the
surfactant molecule. The surfactant with large headgroup and small acyl chain (Type:
Inverted cone) constructs the normal micelle in an aqueous solution. The micelle is the
simplest and smallest structure among the self-assemblies (less than 100 nm). The
hydrophobic part of the surfactant interacts with each other by the hydrophobic effect
and its hydrophilic part is exposed to the surface in contact with water solution. A
vesicle is one of the self-assemblies, composed of the surfactant with a spatial geometry.
For example, a phospholipid has a headgroup and the acyl chain with the same size
(Type: Cylinder). The vesicle size is the larger than the micelle size (50 nm - 100 pm).
A vesicle forms lipid bilayer with the inner aqueous phase.
Surfactant vesicle shows the unique feature by forming the lipid bilayer (Table
1). The membrane properties are known to affect the "membrane-re1ated" behavior,
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Fig。l Schcmatic illustration of sclf―assembly structures,such as llnicelle and vcsicle.
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such as membrane fusion, and the membrane interaction with other molecules or other
membranes. It is expected that the understanding of these membrane properties can
contribute to the control of the membrane-related behaviors. A vesicle composed by the
phospholipids is especially known as the liposome. The membrane properties of the
liposome are regulated, depending on the composition of the phospholipids. The
following characteristics are known as common properties of the liposome. (1) The
membrane fluidity is reduced when the liposome is prepared by not unsaturated lipid,
but saturated lipid. (2) The phase separation of the liposome is induced by the mixing
unsaturated lipid with saturated lipid or steroid (i.e. phospholipid with cholesterol). The
ratio of these lipids affects the size of the phase separation and the phase separation
temperature. (3) When the anionic lipid such as phosphatidylserine is inserted into the
liposomal membrane, the surface charge of the liposomal membrane is turned to
become anionic. It is important to characterize the membrane properties which can be
evaluated based on different kinds of principle.
Table L Membrane properties and its measuring method
Membrane property Material/Method Measuring mechanism
Particle size
Phase tra nsition temperatu re
Zeta potential
Membranefluidity
Phase separation
Polarity
light scatteri ng photometer
(DLS)
differential sca n ni ng ca lorimeter
(DSc)
Zeta potential measu rement
system
DPH
TMA-DPH
Pyrene
Lau rda n
Prodan
ANS
Light scattering
Differentia I sca nning calorimetry
Electrophoresis method
An isotropy of flu orescence
Di mer/Exci mer fl uo rescence ratio
Stokes shift
Flu orescence i ntensity
The cells are surrounded by the plasma membrane composed of the
phospholipids (Fig. 2), which can alsci be used for the liposoine preparation. The plasma
membrane has also been characterized in relation to the membrane properties. The
plasma membrane contains many kinds of membrane protein, resulting in its complex
structure as compared with the liposome membrane. The plasma membrane also
functions as the "foothold" of the membrane protein for its work. The plasma membrane
can thus accumulate various kinds of relating proteins (e.g. Fas and FADD), on its
surface. Membrane protein complex can induce its function in the hydrophobic
environment provided by the lipid bilayer membrane. Moreover, phospholipids are
modulated by the sugar chains, where the type of sugar chain is varied among the cell
lines. The properties of the plasma membrane are thus related well with the molecular
assembly structure at the hydrophobic-hydrophilic interface of the lipid bilayer
membrane.
The cells also regulate the membrane properties by themselves. (1) The most
important role of the plasma membrane is the compartmentation of various
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Fig.2 Schematic illustration of simple scheme of the plasma membrane.
biomolecules against the extracellular environment. The existence of the plasma
niembrane can retain all'the biomolecules into the cytoplar*, *a canprotect them from
external reagent (ion, water molecule, or toxin). When cationic ion inflows into the
cytoplasm by the injury of the plasma membrane, the cells are attempt to reconstruct the
plasma membrane in order to inhibit the inflow of the cationic ion. Therefore, the
plasma membrane is necessary for cells to live. (2) The plasma membrane is the
platform which proteins can work. A lipid raft", a tiny domain containing large amounts
oicholesterol or sphingolipid, is well-known as the protein accumulation site (e.g.
G-protein and receptor). The membrane fluidity of the lipid raft is locally reduced as
compared with that of other part of the plasma membrane. The acylation of G-protein
can induce the accumulation in the lipid raft. The signal transduction, relayed by this
G-protein receptoE is known to be localized into the same lipid raft. The function atlon
the plasma-membrane can thus be related with the properties of lipid membrane, and its
function can be modulated there.
The membrane properties are related not only to the membrane function, but
also to the cell death. There are various reports on the feature of cell death induced by
various mechanisms (Table 2 and. Fig. 3). The membrane is one of the key factors to
determine the cell death. Apoptosis has previously been investigated, especially
focusing on its relationship with the alteration of membrane properties. Apoptotic
process is well-known as the programmed cell death, and is also one of the cellular
response relating well with the response of the plasma membrane. It is known that there
are two typical responses in the case of apoptotic cell membrane; (i) exposure of
phosphatidylserine (PS), and (ii) apoptotic bleb (Kepp et a1., 2011, Melino et al., 2005,
Orrenius et al.,20II). PS usually localizes in the inner leaflet of the plasma membrane
Table 2 Relationship betweell cdl death mechanism and the feame
Necros:s       Apoptos:s
????‐?
Genetic Program
Membrane
Emymes
Receptors
Regulators
None
Lyaed
Lysed
Blown
None
Yes
lntact
P9) exposure
Intact
Intact
Chr. condens
DNAfragm.
Caspase
Death Rec.
Bclfamily
IAP
t ) PS : phosphatidylserine
Fig.3 SchmatiO inustration oftypical ce1l death cneCrOsiyapoptosisI
(Leventis and Grinstein, 2010). Membrane protein, flippase, maintains the asymmetry
of membrane component between inner bnd outer leaflet by using ATP (Hirt and Leiit,
2003, Krijnen et al., 2010). However, the exposure of PS may result in not only the
inhibition of the flippase, but also the calcium-dependent activation of scramblase
(Krijnen et a1., 2010, Suzuki et a1.,2010). PS can thus be regarded as a marker of
"corpse" (Fadeel and Xue, 2006)- Macrophage can immediately engulfs the apoptotic
cells with the exposure of PS to outer leaflet, and can release anti-inflammatory
cytokines (i.e. TGF-B, PGEZ,IL-10) in order to inhibit the inflammation (Nagata et al.,
2010). Apoptotic bleb can also be observed as a morphological alteration (Kepp et al.,
2011, Orrenius et al., 2011). In recent years, it has been reported that the kinase
(ROCK-I, MLCK) and the serine threonine kinase (p38MAPK) can be related with the
apoptotic bleb (Banos et al., 2003, Mackenzie et a1.,2005). However, the mechanism of
the apoptotic bleb has not been clarified entirely. As mentioned above, the relationship
between plasma membrane and apoptotic mechanism has been studied for long time,
although there are still unknown mechanisms.
There are many difficulties in the case of the delivery of the drug into the
diseased cells. Due to the immune system in a human body, only a few percentages of
drugs can be accumulated in the diseased site in apractical trial, resulting that almost all
drugs are excreted from the reticuloendothelial tissue. Even if the drug could be
fortunately accumulated in the diseased site, it would be difficult for the drug to be
transferred from the extracellular matrix to the cytoplasm. This is because the cell was
enveloped by the plasma membrane composed by phospholipids. It is hence difficult to
deriver the drugs, especially hydrophilic drug, or large drugs with higher molecular
weight. The drugs need to be directly delivered to diseased cells in order to achieve an
effective chemotherapy. The use of the drug carrier can solve this problem. Many kinds
of drug carrier were developed in order to effectively deriver many kinds of substances,
such as drug, DNA, RNA, and protein to the diseased cells (Table 3 and Fig.4)'
The interface of the drug carrier is an important target to be designed for the
regulation of the pharmacokinetics (Fig. 5). There have been many reports on various
kinds of drug carriers. (i) Retrovirus vector, used as the effective gene delivery carrier,
Table 3 Summary of drug carrier
Name Carrier Drug Clinical Stage Citation
NK1O5
NC-6004
NKO12
Doxil
Myocet
LE-5N-38
AmBisome
Span 80 vesicle
Rexin-G
Abraxane
Micelles
Micelles
Micelles
Pegylated
liposome
Liposome
Liposome
Liposome
Niosome
Retrovirus
Protein
aggregation
Paclitaxel
Cisplatin
sN-38
Doxorubicin
Doxorubicin
sN-38
Amphotericin B
ESA
mutant form of
cyclin G1 gene
Paclitaxel
P2
PI/2
P2
Approved
Approved
P2
Approved
the Approved
Approved
(Kato et al.,2OI2l
(Baba et al.,2OI2l
(Nagano et al., 2009)
(Lasic, 1996)
(Mross et al., 2004)
(Zhang et al., 2004)
(Hiemenz and Walsh, 1.996)
(Omokawa et al., 2010)
(Morse, 2005)
(Kratz and Elsadek, 2012)
Niosome Retrovirus Protein aggregation
Fig. 4 Schematic illustration of various drug carriers
(i)Gene delivery by retrovirus
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(ii) Hydration layer (Stealth effect)
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Fig. 5 Schematic illustration of surface of drug carrier and strategy in the drug
delivery system
has a viral envelope. This viral envelope is mainly composed by the phospholipids
derived from donor, and contains proteins to be derived from viral gene and to promote
the membrane fusion. As a result, the retrovirus vector finally releases DNA or RNA
into the cytoplasm. (ii) Polymer micelle can often be used as a drug carrier, where the
outside of the micelle is composed by the poly(ethylene glycol) (PEG) unit to induce its
"stealth" effect. PEG alters the drug carrier into the hydrophilic surface, resulting in the
escape from the engulfment of macrophage. (iii) Moreover, the pegylation effect for the
circulation time has demonstrated by the comparison between pegylated liposomal
product (Doxil@) and non-pegylated liposomal product (MyocetrM). The pegylation
?
?
?
?
?
●
Mice‖
Pegylated liposome
dominantly extends the drug halflife in the blood from 2…3 hours to>55 hours(Rivera,
2003)。(i⇒The entf¨ped Cfflciency can also be regulated by面e surface prop rties of
the drllg carricn Doxil①, which is especially famous liposomal product, is the
doxorubicin hydrochlo五de(DOX)cnCapSulated by pegylated liposome with higher
entrapping efflcicncy because ofthe pH gradicnt across the mcmbrane.
Thus,there are various kinds of drug carriers,where new types of drug carriers
are still being designed and devcloped■ow by``trial―and―error"strategy.These drug
carri∝s havc been evaluated in relation to the individual propertics, such as drllg
enёapsulation efflcicncヌor drug pcrlneability or rationally.Howcver these drug carricrs
arc not designed systematically.It is important to dcsign the drug carricr according to
various indexes analyzed based on the different principles.The lncmbrane properties arc
hcnce expectcd to be uscd as the index of the design of drug carien Thc membrane
propertics are thus shown to be thc kcy factor to dccide the rnembrane―related behavioち
suggesting their relation with the ``mcmbrane¨Inembrane'' illteraction. A variety of
siategics to increasc the accumulation ofomgs intO the diseasc site have been repo■cd
by mOdiiCation of the protcin,focusing on the funCtiOn Of protein.Howevet the
important rolo of``nlcmbrane itsclf'in the drug carrier design has not been proposed
yct.
The inal purpOse ofthis study is to establish the stratcgy to design an efflcicnt
membrane surface by using a surfactant vesicle for a novcl drug delivery systcm.The
mmbranc prOperties of surfactant vcsicles were irst characte五zcd in order to clarify
the key paramcters relating to the``rnembrane―rela ed''phenomen .After the lnethod to
control thc``rrlembranc―Inembr e''interaction was clarifled among different kinds of
surfactant vesiclcs,the rnethodology has becn applied to thc dcsign and devcloplnent of
different kinds of drug delivery system using surfactant vesicles.
The framework and flowchart of this thesis are shown in Figs. 6 and, 7
respectively.
In chapter 1, various kinds of surfactant vesicles were characterized by using
fluorescence probe method and dielectric dispersion analysis method. These surfactant
vesicles were characteized, focusing on various kinds of membrane properties,'oJluit',
"flexible" and"wef', which differ in their principle. After the membrane properties of
various kinds of surfactant vesicles were characteized. the above vesicles were
categoizedbased on the above three properties.
In chapter 2, the relationship between the membrane properties and
oomembrane-membrane" interaction was systematically investigated. The membrane
properties, obtained in chapter 1, were correlated with the interaction phenomena.
According to these results, the scheme for the design of drug carrier was finally
established.
In chapter 3, the possible application of the designed surfactant vesicle was
studied based on the above findings. A design scheme on the appropriate membrane
surface of drug carrier was proposed considering the membrane-membrane interaction
between the vesicle and biological cells. Some case studies, such as (i) DOX delivery
using Span 80 vesicle, (ii) induction of Pseudo-Apoptosis of cancer cell, (iii)
intracellular organelle targeting using vesicle-in-vesicle, and (iv) active targeting to
cancer cells, were employed to show the significance of this scheme.
The results obtained in this work are summarized in the General Conclusion
section. Suggesting for Future Work is described as extension of the present thesis.
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Chapter I Characterizatioh of Membrane Properties of Surfactant-Vesicles
-Composition of Span 80 Vesicle and Phospholipid Vesicle (Liposome)-
1. Introduction
Drug delivery composes of many elemental steps: the drug permeation (Ashley
et al., 2011); the accumulation of drug carrier to the disease site (Omokawa et al., 2010);
the retention time in the blood vessel (Lasic, 1996); and uptake (Fig. 1-1). Recently,
those phenomena have withdrawn much attention as the membrane-relating phenomena.
This is because the above phenomena are largely affected by the membrane properties
and states. It is therefore implied that one can design the drug delivery system by tuning
the membrane properties to control the drug permeability from drug carrier, its
accumulation to the disease site, and the retention time in the blood vessel.
Drug carrier
/- (Surfactantvesicle)
Fig. 1-1 Scheme of drug delivery ("membrane-membrane" interaction)
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It is the″θ
“
b“4θノZιJ訪ケthat has been irst investigated from the宙wpoint
whether the membrane property would be a key factor for a control‐of
IIlembrane¨elating phenomcnao Membrane fluidity is one of well―known indexes ofthe
lateral di]bsion of lipid molecule,and has been rcported to be related with the drug
pe■11leability(Shimanouchi et al。,2009).Doxil①,a collIInercial drug using lipid vcsicle
modiflcd with PEG,is rationally designed based on the membrane propcrties.Doxil① i
usually prepared by hydrogenated soy phosphatidylclЮlinc(saturated lipids)and
cholcstcrol(Lasic,1996).■haS been reported that the saturated lipids can forln
liposome at gel phase, while the unsaturated lipids do at liquid crystalline phase
(Koynova and Caffrey 1998).A liposome at gel phase is known to show the lower
membrane fluidity as compared with that at liquid crystallinc phase(Bakht et al.,2007).
Thc inscrtion of cholesterol illto the lipid lnembrane contributes to the physical structure
of the bilayer membrane,resulting in the signiflcant reduction of the pe....eability of
drug from liposome(Pugh et al。,1989)。ThuS,it is a coIIllnon inding that the membrane
fluidity is an adequate parameter to characte五ze the membrane property.
Membrane fluidity has been also reported to be related with the
membrane―llnembrane interactiono When a liposome binds to a plasma lnembranc ofthe
biological cell,the cell uptakes the liposomO by ision,endocytosis,or phagocytosis
(Dizgiine,and Nit 1999)。It has been reported that the membrane■uidity could
contribute to the uptake mechanism by cells.Liposome ohoSphatidylglycerol :
phosphatidylcholine=1:9)at liquid crystalline phase has been reported to induce its
ision with the plasma membrane to an extreme extellt as compared with that at gel
phase(PapahattOpOu10s et al.,1973).ThiS pre宙ous inding clearly shows that the
membrane nuidity rather than the electrostatic interaction might dominate thc
14
membrane-membrane interaction. From another point of view, when a liposome is
injected into the blood vtirssel, the liposome binds to the blood proteins, such as albumin,
globulin, or opsonin protein. It has been reported that the amount of rat semm albumin
bound to the liposome can be increased by the increase of liposomal membrane fluidity
(Dimitrova et al., 2000). The binding affrnity of opsonin, biomolecule that targets on
antigen, to liposome is especially important to understand the pharmacokinetics.
Opsonization can promote the engulfment of macrophage, resulting in the reduction of
the concentration of the drug in the blood vessel (Chonn et al., 1992). It has also been
reported that there could be a relationship between the membrane fluidity of its
liposome and its pharmacokinetics (Moghimi and Patel, 1989). Therefore, the control of
membrane fluidity is important for the design of membrane-related phenomena,
including the effective drug carrier.
Along with the reports based on the spectroscopic study using the variety of
fluorescence probes or the direct imaging, it has been revealed that the membrane could
be charactenzedby the physicochemical properties in addition to the membrane fluidity.
Fig. 1-2 Structure of (a) surfactant vesicle and (b) lipid bilayer.
15
Membrane-related phenomena are not always explained only by membrane fluidity. For
example, the headgroup mobility on the membrane suriace directly affects thb surface
property that could govern the membrane-membrane phenomena. Usually, vesicles
composed by the amphiphiles, such as surfactant, frdy expose their hydrophilic
headgroup to aqueous phase surrounding the vesicle (Fig. 1-2). It is suggested that the
headgroup mobility can directly affect the interaction with the plasma membrane or
proteins. Among the possible surfactants, a phosphocholine has a permanent dipole in
its headgroup structure. The headgroup of phosphocholine molecules on the membrane
interact with each other, resulting in the formation of highly-ordered structure on the
surface. The lipid membrane also shows its fluid nature, caused by intense mobility of
the headgroup. It has been reported that the headgroup mobility is well correlated with
the membrane fluidity (Shimanouchi et al., 2011). Alternatively, the dynamics of the
membrane can affect the polarity of the membrane. Vesicular membrane is composed by
hydrophilic part (headgroup region) and hydrophobic part (acyl chain region). Water
molecules can be inserted hardly into the vesicular membrane of hydrophobic part,
while some water molecules exist in the hydrophilic part of the vesicular membrane to
some extent (Wiener and White, 1992). The existence of water molecules in the
membrane is dependent on the liposomal phase. When the membrane exists at gel phase,
the phospholipid molecules are tightly anayed on the membrane. The mobility of the
phospholipids on the membrane is reduced. It is difficult for water molecules to be
inserted into the slight cleavage of the liposomal membrane in such a situation. On the
other hand, the phospholipid molecules are flexibly arrayed on the membrane in the
case of the liquid crystalline phase (Koynova and Caffrey, 1998), and can move
dynamically on the membrane surface (Shimanouchi et aI.,20II).It is easy for water
16
molecules to be inserted into the membrane of not only hydrophilic part, but also
hydrophobic part in this case as compared with liposome at gel fhase (Stepniewski et al.,
2011).
ln this chapter, vesicles were characteized according to the membrane
properties, such as membrane fluidity, headgroup mobility, and polarity, by contrasting
them with other formulations such as water-in-oil emulsion (Table L-L and Fig. 1-3).
The fluidity of the membrane was evaluated by using both fluorescence probe,
1,6-diphenyl-1.3.S-hexatriene (DPH) and trimethlyammonium-DPH (TMA-DPH).
Membrane fluidity can herewith be defined as the resolution of fluorescence anisotropy.
It has been reported that DPH and TMA-DPH localized into the inner and surface of the
membrane, respectively (Borenstain and Barenholz, 1993). The previous findings
indicate that DPH and TMA-DPH show the membrane fluidity of inner and surface
membrane, respectively. The flexibility is defined the dipole moment of headgroup of
surfactant vesicles. The headgroup mobility was evaluated by using the dielectric
dispersion analysis. The polarity is defined the existence of water molecule, which can
Table 1-1Analytical method of membrane properties
Region Material/Method
lnner
Surface
Surface
lnner
Surface
DPH
TMA-DPH
lmpedance analyzer
Laurdan
ANS
Membrane Fluiditywas evaluated by the
fluorescence anisotropyof DPH or TMA-DPH.
Head group mobilitywas evaluated bythe specific
frequency of hea d grou p structu re.
Membrane polaritywas evaluated by the
fluorescence intensity or spectra
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be evaluated by environmentally-responsive fluorescence probe. 8-Anilino-1-naphthale-
nesulfonic acid (ANS), and 6-dodecanoyl-N,N-dimethyl-2-naphthylamine (Laurdan)
have been previously reported to be inserted into the membrane surface, and inner
membrane, respectively (Bagatolli et al., 1999, Slavik, 1982). The existence of water
molecules was analyzed form the alteration of the fluorescence intensity and the peak
sift of both fluorescence probes (ANS and Laurdan). Based on the results obtained here,
the novel viewpoint to characterize surfactant vesicles indicated that the membrane
property could be categorized by fluid, flexible, and wet. These viewpoints would give
the better understanding to design the effective drug carrier.
ANS
pNЮム
Fig. 1-3 (a) The chemical structure and (b) location into the membrane of the
fluorescence probe, DPH, TMA-DPH, Laurdan and ANS. DPH and Laurdan were
inserted into the inner membrane. TMA-DPH and ANS were inserted into the
membrane surface.
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2. Materials and Methods
2.1. Materials.
Sorbitan monooleate (Span 80) and polyoxyethylene sorbitan monooleate
(Tween 80) were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Phospholipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1,2-dimirystoyl- sn-glycero-3-phosphocholine (DMPC), and I,2-dipalmitoyl-sn-glycer-
o-3-phosphocholine (DPPC) were purchased from the NOF Corporation (Tokyo, Japan).
8-Anilino-1-naphthalenesulfonic acid (ANS) and 1,6-diphenyl-1,3,5-hexatriene (DPH)
were obtained from Molecular Probes Inc. (Eugene, OR, U.S.A.).
6-Dodecanoyl-N,N-dimethyl-2-naphthylamine (Laurdan), N,N,N-trimethyl-4-(6-pheny-
l-1,3,5-hexatrien-1-y1) phenylammonium p-toluenesulfonate (TMA-DPH), and
cholesterol were purchased from Sigma-Aldrich and AnaSpec Inc. (Fremont, CA, USA),
respectively. Lysozyme was obtained from Seikagaku Co. (Tokyo, Japan).
2.2. P reparation of liposome
Phospholipids and cholesterol were dissolved in a chloroform solution. The
organic solvent was removed by evaporation in a rotary evaporator. The residual lipid
film, after drying under a vacuum overnight, was hydrated with the inner-phase liquid
(distributed water or phosphate-buffered saline (PBS; 137mM NaCl, 2-9mM KCl,
10mM NazHPO+, 2mM KHzPO+; pH 7.3). The suspension was subjected to five cycles
of freezing and thawing and then extruded. The lipid concentfation was determined by
phosphorous analysis.
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2.3. Preparation of Span 80 vesicle.
Span 80 vesicle was prepared by the two-step emulsification method (Kato et
a1.,2006) , as shown in Fig. l-4. 6 ml of n-hexane solution containing Span 80 and
cholesterol was added to 0.6 ml of inner-phase liquid (distributed water or PBS),
followed by the first emulsification for 6 min at 17,500 rpm using a micro-homogenizer
NS-310E 2 (Microtec Co., Ltd., Funabashi, Japan). The solvent obtained from the
water-in-oil emulsion was evaporated in a rotary evaporator at 28 oC under reduced
Two step emulsification method
System
w/o emulsion
lnterface
0‖phase              O/VVVesicle Pegylatedvesicle
Fig. 1-4 Schematic illustrations for two step emulsification technique and the interface of
various systems. (a) First emulsification. Span 80 was homogenized with water
droplet in the n-hexane solution. (b) The n-hexane solution was removed by
evaporator. (c) w/o emulsion was suspended and homogenized into the water
solution containing Tween 80, resulting in the formulation of vesicle. (d)
Pegylation. When TWeen 80 solution contain pegylated lipid, the pegylated lipid
enter the vesicular membrane.
b)
ゞ3ヽ町
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pressure, yielding a waterJipid emulsion to which 6 ml of outer-phase liquid
(distributed water or PBS) iontaining 96 mg of TWeen 80 was added,'followed by
mixing with the homogenizer for 2 min at 3,500 rpm to obtain the heterogeneous Span
80 vesicle suspension. The heterogeneous vesicle suspension was stirred with a
magnetic stirrer for 3 hours at room temperature, followed by storage overnight at 4 "C.
The vesicle was then purified by ultracentrifugation (50,000 rpm at 4 oC for 120 min) in
a Himac centrifuge CR15B (Hitachi Koki Co., Ltd., Tokyo, Japan). The purified Span
80 suspension was passed through 100-nm nucleopore track-etch polycarbonate
membranes and purified twice by ultracentrifugation.
2.4. Measurement of membrane fluidity.
Membrane fluidity was evaluated with the anisotropy of the fluorescence of
DPH and TMA-DPH (Hayashi et a1., 2011, Kato et al., 2008). DPH or TMA-DPH
solubilized in ethanol was added to a pre-formed vesicle suspension to give a
lipid/probe molar ratio of 250 ([(TMA-)DPH]6,a1 : 1 pM). Then, the mixture was
incubated at least for 30 min at room temperature under gentle stirring. The
fluorescence polarization of the samples was measured with an FP 6500
spectrofluorometer (JASCO, Japan) equipped with a polarizer. The sample was excited
with vertically polarized light (360 nm), and the emission intensity (430 nm) both
parallel and perpendicular to the excited light was recorded. The temperature was kept
at 35 oC. Then, the polaization of DPH and TMA-DPH was calculated from the
following equation:
P=(I°
°°~Groo9。。)
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(1-1)
r' 
- 
I9o'o'
" - Iro""o'
Since polaization is inversely proportional to fluidity, membrane
expressed as I/P.
(1-2)
fluidity is
2.5. Dielectric dispersion analysis.
An impedance analyzer (RF impedance analyzer 42918; Agilent Technologies,
Palo Alto, CA) equipped with a handmade brass electrode cell was used to measure the
dielectric spectra of liposome suspension in the frequency range between 1.0 MHz and
1.0 GHz. The dispersion was analyzed from the following equation consisting of fourth-
or fifth-type Debye's equation (Shimanouchi et al.,20ll).
♂ =Σ柵 (1-3)
It has been reported that the liposome suspension has four different characteristic
relaxations: the lateral diffi.rsion of ionic species (i : 1, first-step, several MHz); the
mobility of lipid headgroup (i:2, second-step, 
-50 MHz); the water bound to liposome
membranes (i : 3; third-step, 200-500 MHz); the bulk water (i : 4, fourth-step, 
-20
GHz). Therefore, equations (2) and (3) were assumed to be written by a summation of
four relaxation terms. In general, the large /; represents the rapid mobility of target
materials.
2.6. Evaluation of membrane polarity.
Hydrophiliclhydrophobic characterization of the membrane of vesicles was
evaluated by the environmentally sensitive fluorophore ANS and Laurdan at 35 oC
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(Parasassi et a1.,1994, Slavik, 1982). ANS or Laurdan solubilized in ethanol was added
tb a pre-formed vesicle'suspension to give a lipid/probe molar ratio'of 100 ([ANS]n"ur,
[Laurdan]6nat : I pM). Then, the mixture was incubated at least for 30 min at room
temperature under gentle stirring. ANS was excited at 350 nm, and the emissions were
observed from 375 nm to 600 nm; Laurdan was excited at 340 nm and the emission
spectra were observed from 425 nmto 550 nm with FP-6500 fluorometer at 35 oC.
The Laurdan emission spectrum has a red shift due to dielectric relaxation
(Stokes shift). The emission GP spectra were calculated by measuring the GP value for
each emission wavelength as follows:
Gp(s+o) _ (r++o_r+go)(1440+l4eo)
Ia,qo:The fluorescence intensity of Laurdan at 440 nm
1+qo: The fluorescence intensity of Laurdan at 490 nm
(1-4)
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3. Results and Discussion
3.1. Characterization of Membrane Fluidity.
In the first series of experiments, the interface structure of each system was
investigated by using rodJike fluorescence probes because their intramolecular
rotational motion was sensitive to the ordered-structure of the interface. The
intramolecular rotational motion of two fluorescence probes, DPH and TMA-DPH, was
herein quantified with their polaization (P) whose reciprocal value represents the
mobility of both (Lentz,1993, Shimanouchi etal.,z}ll).
Figure L-5 shows the (llP) value of DPH and TMA-DPH in the variety of
systems described in Fig. L-4. Overall, the order of (IIP) value of DPH and TMA-DPH
were (1,2) > (3-6). Since Span 80 molecules can move at the interface between water
and hexane, the intramolecular mobility of DPH and TMA-DPH can be allowed, which
Fig. 1-5 Mobility of (a) DPH and (b) TMA-DPH in various systems (37 "C).The value
was evaluated by the polarization.
﹇?
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(1) Hexane (1) Hexane
(2) Inverted micelle
{3) DMPCliposome
(4) Pegylated DMPcliposome
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is consistent with their large value of (llP) in the system of (1) and (2).In contrast, the
supramolecular asdemblies, such as phospholipid vesicle (liposome) and Span 80
vesicle, indicated the low mobility of DPH and TMA-DPH. This is because the mobility
of DPH and TMA-DPH orientated into the acyl chain region of phospholipids or Span
80 molecule was easily restricted. Furthermore, comparing the DMPC liposome (3,4)
with the Span 80 vesicle (5,6), the mobility of DPH was the following order: (3, 4) < (5,
6). In contrast to DPH, the mobility of TMA-DPH was (3, 4) > (5, 6). The interface of
Span 80 vesicles is composed of sorbitol as headgroup. It is therefore considered that
TMA-DPH orientated into the deeper region. In addition, the significant effect of
induction of PEG layer to liposome and Span 80 vesicle was not observed. It is
suggested that the mobility of lipids was restricted in the formation of vesicle from the
inverted micelle.
Alternatively, cholesterol was used to clariff the eflect on membrane structure.
POPC liposome (liquid crystalline phase), DPPC liposome (gel phase), and Span 80
vesicle were examined because cholesterol was considered to affect the membrane
structure, depending on the phase state of membranes. The membrane fluidity measured
by DPH is shown in Fig. 1-6(a). DPPC liposome shows low membrane fluidity ((llP)
of DPH : 3.10) with DPH, while POPC liposome shows high membrane fluidity ((llP)
of DPH : 9.71).The membrane fluidity of the Span 80 vesicle ((IlP) of DPH : 13.3)
shows higher than other vesicles. The membrane fluidity measured by TMA-DPH is
shown in Fig. 1-6(b). The obtained results on the membrane fluidity of the Span 80
vesicle by using TMA-DPH was found to be not similar with the membrane fluidity
using DPH, in contrast to the case of DPPC and POPC liposome. The membrane
fluidity of DPPC liposome ((IlP) of TMA-DPH : 3.19) is lower than
25
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Fig. 1-6 Membrane fluidity measurements carried out at 35 oC. The membrane
fluidity was evaluated as a reciprocal of polarity (P). The molar ratio of DPH
and TMA-DPH to vesicles l:250. The data with standard error were obtained
from three independent experiments.
that of POPC liposome ((llP) of TMA-DPH : 5.14). However, the membrane fluidity
with TMA-DPH of Span 80 vesicle is lower than that of POPC liposome, in spite of the
highest membrane fluidity of Span 80 vesicle with DPH. In order to evaluate the
membrane fluidity more in detail, the alteration of the membrane fluidity of vesicle was
observed by modifying the vesicle membrane with cholesterol. The alteration of
membrane fluidity with DPH is similar to that of TMA-DPH. No alteration in the
membrane fluidity of DPPC liposome was observed, while the membrane fluidity of
POPC liposome was reduced in the case of cholesterol modification. On the other hand,
there is a difference of the effect of cholesterol on the membrane fluidity of Span 80
vesicle in the case of DPH and TMA-DPH measurements. The addition of cholesterol
was found to reduce the membrane fluidity when DPH was applied to the measurement
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in the case of Span 80 vesicle. On the contrary the membrane fluidity with TMA-DPH
of Span 80 veisicle shows a similar Value regardless of the iontent of cholesterol. '
Membrane fluidity is dependent on the lipid composition of liposome, such as
hydrophobic groups saturated or unsaturated acyl-chain (Koynova and Caffrey, 1998).
DPPC is saturated lipid, and can form a liposome at gel phase. POPC is unsaturated
lipid, and can form a liposome at liquid crystalline phase. Therefore, the membrane
fluidity of DPPC liposome is lower than that of POPC liposome. The membrane fluidity
of Span 80 vesicle is also higher than that of DPPC liposome, suggesting that the Span
80 vesicle membrane exist at liquid crystalline phase. However, there is a difference of
the membrane properties between POPC liposome and Span 80 vesicle, in spite that
they both exist at the same liquid crystalline phase. It is well known that the cholesterol
can reduce the membrane fluidity of liquid crystalline phase. The membrane fluidity
with TMA-DPH of POPC liposome is reduced by adding cholesterol, while no
reduction in the membrane fluidity with TMA-DPH was observed in the case of Span
80 vesicle. It is suggested that the above phenomena can be to be related with the
localization of TMA-DPH molecule in the membrane. It has been reported that the DPH
and TMA-DPH molecules localize inlo the inner and surface of liposome membrane,
respectively (Borenstain and Barenholz, 1993). The inner membrane structure of Span
80 vesicle is similar to that of liposome (acyl chain region), while the headgroup
structure of Span 80 vesicle (sorbitol) is different from that of liposome
(phosphocholine). It is suggested that the difference of headgroup structure affects the
role of cholesterol for the membrane and localization of TMA-DPH on the Span 80
vesicle membrane, resulting in no alteration of membrane fluidity with TMA-DPH of
Span 80 vesicle by adding cholesterol.
27
3.2. Characterization of Headgroup Mobility Using Dielectric Dispersion
Analysis.
Headgroup mobility of vesicle at liquid crystalline phase (POPC liposome and
Span 80 vesicle) was analyzed by using an impedance analyzeq as shown in Fig. 1-7.
The dispersion of the dielectric spectra of liposomes was observed at a specific
frequency region from 20 MHz to 300 MHz (Shimanouchi et aI.,2011). The above
result attributed to the motion of the zwitterionic headgroup of lipid inside the liposome
membrane. A specific frequency of POPC liposome was observed at 60 MHz.
Cholesterol was added to the membrane to alter the membrane properties, as described
above. The dielectric dispersion that attributed to the headgroup of lipid molecule was
shifted to a low-frequency range with the increase in the cholesterol content. This result
suggests the restriction of the headgroup mobility of the POPC molecule via its
interaction with cholesterol. A different result was obtained, when Span 80 vesicle or
400 O Span80 vesicle
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Fig. 1-7 Dielectric dispersion parameters of Span 80 vesicle and liposome. The
relaxation frequency of Span 80 vesicle was constant with cholesterol
concentration against cholesterol dependence on POPC liposome.
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Span S0/cholesterol vesicle were analyzed. The specific frequency of Span 80 vesicle
headgroup was observed at'243 MHz, being higher than that of POPC liposome
headgroup. This value was not varied when the cholesterol content was changed.
These results correspond well with the results on the membrane fluidity of the
membrane surface, as described above (Fig. 1-6), where the membrane fluidity with
TMA-DPH of POPC liposome was reduced, and the specific frequency of POPC
liposome headgroup was shifted to a low-frequency range by adding cholesterol. The
addition of cholesterol reduces the mobility of the phospholipid itself (lateral diffi.rsion
and headgroup mobility). The obtained higher value in the specific frequency of the
headgroup on Span 80 vesicle suggests the high mobility of headgroup on the vesicular
membrane. It is considered that Span 80 vesicle has an induced-dipole on the headgroup
(sorbitol structure), resulting in a weak electrostatic interaction between the molecules
as compared with the case of liposome. The effect of cholesterol on Span 80 vesicle also
supported the high headgroup mobility. Cholesterol can affect the inner membrane of
Span 80 vesicle similarly in the case of liposome (Fig. 1-6(a)), while the headgroup
region is not affected in spite of the cholesterol coexistence by the contribution of high
headgroup mobility, different from the case of liposome (Figs. 1-6(b) and 1-7).
3.3. Characterization of Membrane Polarity.
The intense mobility of lipid at the interface of membranes resulted in the
exposure of hydrophobic environment of membranes (Flanagan and Hesketh, 1973). It
has been reported that the hydrophobic fluorescence probe ANS can emit the large
fluorescence intensity if ANS exists in the hydrophobic environment. The ANS
fluorescence intensity for various systems was therefore measured as shown in Fig. 1-8.
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The order of ANS intensity was (1, 2) > (3,4) > (5, 6), indicating that Span 80 vesicles
have the quite hydrophilic surface. Meanwhile, the pegylation of liposome and Span 80
vesicle indicated no remarkable change in hydrophobicity, implying no binding of ANS
to PEG layer or no difference in hydrophobicity between PEG layer and bulk aqueous
phase.
Similarly in the case of (TMA-)DPH, the effect of cholesterol to the membrane
structure was investigated in terms of the hydrophobicity. Herein, POPC liposome
(liquid crystalline phase), DPPC liposome (gel phase), and Span 80 vesicle were
examined because the cholesterol is consider to affect the membrane structure"
depending on the phase state of membranes. The difference of ANS fluorescence
intensity is shown in Fig. 1-9. The fluorescence intensity of ANS in the POPC liposome
(1: 80.8) was higher than that of ANS in the other vesicle. Cholesterol was found to
reduce the fluorescence intensity of ANS in the POPC liposome. The fluorescence
intensity
(1) Hexane
(2) Inverted micelle
(3) DMPC liposome
(4) Pegylated DMPC
(5) Span 80 vesicle
(6) Pegylated Span 80 vesicle
(2) (3) (4)   (5) (6)
Fig.L-8 ANS fluorescence
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Fig.1-9 Hydration as a function of cholesterol ratio increasing. Fluorescence spectra
of ANS probe in Span8O vesicle and liposome membrane at different amount
of cholesterol containing at 35 oC.
of ANS in the both of DPPC liposome (I : 22.5) and Span 80 vesicle (/ : 12.1) was
lower than that of POPC liposome. Cholesterol did not reduce the fluorescence intensity
of ANS in the both DPPC liposome and Span 80 vesicle. ANS inserts into the
membrane surface of vesicle, and it has been reported that ANS exists at headgroup
region (Slavik, 1982). ANS monitors the polarity at the headgroup region of the vesicle
membrane. It has been reported that water molecule inserts the liposome at liquid
crystalline phase membrane more easily than that of liposome at gel phase (Stepniewski
etaI.,20lI),while ANS fluorescence intensity of POPC liposome with liquid crystalline
phase is higher than that of DPPC liposome at gel phase. It seems that the tight array of
lipid on the membrane at gel phase prevents the insertion of ANS into the vesicle
membrane. The fluorescence intensity of Span 80 vesicle was lower than that of POPC
liposome, in spite of similar phase state (liquid crystalline phase). The headgroup of
Span 80 vesicle has more d5mamic mobility as compared with that of liposome owing to
the difference of the headgroup structure, as described above (Section 3.2.). It is
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tr POPCliposome
O Span80 vesicle
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suggested that this property can promote the insertion of water molecule into the
membrane oi Span 80 vesicle. Choiesterol has known to form the water accessible site,
resulting in the reduction of ANS fluorescence intensity of POPC liposome (Slavik,
I9S2). Span 80 vesicle with intense headgroup mobility was not affected by the
cholesterol. Span 80 vesicle membrane is already accessible for water molecule either
with or without cholesterol. tn the following, the different probe sensitive to the polar
environment was used to reveal the polarity of Span 80 vesicle as mentioned above.
The polarity of each system was then investigated by using Laurdan (Bagatolli
et al., 1999). The spectrum of Laurdan for system (1) and (2) showed the peak at 435
nm (Fig. 1-10 (a)). ln contrast, the peak of liposomes (3, 4) and Span 80 vesicles (5, 6)
was shifted into the longer wavelength range, suggesting that DMPC liposome and Span
80 vesicles were more hydrophilic than hexane and inverted micelle (W/O emulsion).
This result is compatible with that obtained in ANS binding experiment (Fig. 1-9). To
compare the polarity of the interface of Span 80 vesicle with liposome, the generalized
polaization (GP) values were then evaluated. The order of GP value was same as that of
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ANS binding experiment, indicating the large polarity (hydrophilicity) of Span 80
vesicle. Meanwhile, the induction of PEG layer resulted in no variation in GP value in
both cases of DMPC liposomes and Span 80 vesicles.
The fluorescence spectra of Laurdan in the (a) DPPC liposome, (b) POPC
liposome, and (c) Span 80 vesicle were shown in Fig. 1-11. When Laurdan incubated
into DPPC liposome suspension, the peak of Laurdan fluorescence intensity was
observed at 440 nm either with or without cholesterol. The peak of Laurdan
fluorescence intensity was observed at 490 nm in POPC liposome and Span 80 vesicle
membrane. Cholesterol increased the fluorescence intensity at 440 nm and reduced the
value at 490 nm. [t has been reported that Laurdan inserts deeply into the vesicle
membrane as compared with ANS (Bagatolli et al., 1999). Laurdan monitors the inner
membrane polarity. Both peak at 440 nm and 490 nm show hydrophilic and
hydrophobic environment, respectively (Bagatolli et al., 1999).In this study, the polarity
of vesicle membrane was quantitatively evaluated, by calculating GP1:+o; value (Fig.
l-12) (Parasassi et al., 1994). DPPC liposome membrane is the most hydrophobic as
compared with POPC liposome and Span 80 vesicle. DPPC liposome at gel phase
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Fig. 1-11 Hydration as a function of cholesterol ratio increasing. Fluorescence spectra
of Laurdan probe in (a) DPPC liposome, (b) POPC liposome, and (c) Span8O
vesicle membrane at different amount of cholesterol containing at 35 'C.
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Fig. 1-12 Dipolar reorientation of solvent during Laurdan. Laurdan GPtsot values at
various cholesterol concentrations containing. The percent values represent
molYo of cholesterol in total mol of lipids.
can prevent the insertion of'water molecule into the membrane as described by ANS
regardless with or without cholesterol. The membrane of POPC liposome and Span 80
vesicle is more hydrophilic than DPPC liposome. Cholesterol increased the GP1:+01
value of POPC liposome and Span 80 vesicle. The inner membrane was composed by
the unsaturated acyl chain in the case of POPC liposome and Span 80 vesicle. The
hydrophilic property of inner membrane in case of POPC liposome is similar to that in
case of Span 80 vesicle.
3.4. Fluid, Flexibleo and Wet as a novel index for Membrane Property.
To fully characteize the variety of surfactant vesicles, the alteration of the
physicochemical properties of vesicles was evaluated. Cholesterol is known to
contribute to the maintenance of homeostasis through the modulation of the membrane
properties and its diffrrsion (Maxfield and Tabas, 2005), and to function as a "hardener"
of the lipid bilayer (Pugh et aI., 1989, Shimanouchi et a1., 2009). PEG layer is also
?‐〕（。．?）??）
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known as the inducer of the hydrophilic layer. However, the effects of cholesterol and
PEG are different, depending on the'membrane phase, conientration, temperature, and
membrane component. In this chapter, the membrane polarity, fluidity and headgroup
mobility were characterized in order to reveal differences in the membrane properties of
surfactant vesicles.
As mentioned in introduction of this chapter, the membrane fluidity is one of the
important properties to discuss the variety of membrane-relating phenomena. The
membrane fluidity evaluated by DPH and TMA-DPH was dependent on the phase state,
cholesterol concentration, and component of the membrane (Figs. L-5 and 1-6). These
results suggest that the dynamic property at the surface of the membrane was different
from that at the interior (Figs. 1-13(1) and (2)). This dynamics is caused by the lateral
diffrrsion of surfactant arrayed in the membrane. At the surface, the lateral diffusion was
restricted by the dipole-dipole interaction between headgroups of surfactant and by the
van der Waals interaction between acyl chains of surfactant in membrane. Therefore,
"Fluit'property is considered to be an indispensable property of the membrane.
Fluidity (Lateral diffusion)
lnner Surface
Head group
mobility
TMA-DPH dielectric Laurdan
dispersion analysis
DPH
Fig. 1-13 Total view of the membrane characterization.
ANSMatenaソMethod
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Likewise, the headgroup mobility is an index for the dynamics of membrane
interface. Especially, the headgroup of Span 80 (sorbitol) could move with an intense
mobility (Fig. 1-7), due to the weak interaction between sorbitol. This is caused by the
hydroxyl group of sorbitol could induce the weak dipole-dipole interaction. In contrast,
the phospholipid with a permanent dipole formed the strong interaction between
phospholipids, inducing the reduction of headgroup mobility. As previously reported
(Shimanouchi et a1.,2011), the headgroup mobility can be correlated with the interfacial
dlmamics estimated by the TMA-DPH (membrane fluidity at the surface of vesicle
membranes). In such a sense, it is considered that the headgroup mobility composed of
the flexibility of membrane interface, which is considered as ooFlexible" property of
surfactant vesicles (Fig. 1-13(3)).
By using Laurdan and ANS, the polarity of membrane interface can be evaluated.
Laurdan has a more hydrophobic structure than ANS, implying that it exists in a deeper
region of the vesicle membrane. Actually, the results measured using Laurdan show a
different tendency in the polarity of the membrane as compared with those measured
using ANS (Fig. 1-8 to Fig. 1-1,2). The fluorescence of the Laurdan was evaluated by
calculating general polarity according to a previous report (Hayashi et al., 20II), in
which the membrane of the DPPC liposome showed higher hydrophobicity than that of
the Span 80 vesicle or POPC liposome in the absence of cholesterol (Fig. l-12). DPPC
liposome has a gel phase, and the headgroup of the DPPC molecule is tightly packed. It
is therefore difficult for water molecules to invade into the interior of the membrane
because the rate of relaxation of Laurdan is very small. However, the relaxation of water
dipoles occurred in both Span 80 vesicles and POPC liposomes, suggesting that the
vesicle in the liquid crystalline phase was able to entrap small water molecule in the
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inner membrane. Thus, these surfactant vesicles were considered to have membranes
with " Wbf' characteristics (Figs. 1-13 (4) and (5)).
From the above discussion, the fluid, flexible, and wet was expressed in the
xyz-space as shown in Fig. 1-14. Surfactant vesicles migbt be one of fonnulations in a
style of WO/!V emulsion. The discrepancy in such formulation between surfactant
vesicles including emulsion should be derived from the Wetness of the interface.
Therefore, xy-plane defined as fluid and flexible was adopted as the fundamental plane.
In addition, wetness was adopted as z-axis to discuss the variation of fonnulation of
surfactant. The organic phase and WO emulsion were observed on xy-plane.In contrast,
the formulation such as liposomes and Span 80 vesicle were scattered in xyz-space (z
being not 0). Especially, Span 80 vesicle obviously differs from other formulations,
VVet
(POlarity)
1 Hexane
2W/O emulsion
3 DPPC liposome
4 DMPC liposome
5 POPC liposome
6 Span 80 vesicle
Fig。
Fluid
(Membranettuidたy)
1…14 Schematic illustration on catego五zation
membrane properties(Fluid/Flcxible却輌eつ。
Flexible
(HeadgrOup mobi‖ty)
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f surfactant formulations in
which implies the discrepancy of vesicle preparation. In the following, the influence of
the two-step emuisification on the formulation of Span 80 was discussed based on Fig.
t-14.
It has been reported that Span 80 is capable of forming emulsions with several
hundred micron in diameter, in water I n-tetradecane system under the high Span 80
concentration (Cornec et al., 1996), suggesting the stable partitioning of Span 80 into
the interface of water lhexane system at the first emulsification as shown in Fig. 1-4(b).
The variation of the formulation for Span 80 along with the two-step emulsification
process induced the reduction of hydrophobicity (Figs. L-8 and 1-10), possibly resulting
from the removal of hexane from the formulations of Span 80 at the second
emulsification process. Taking into account the intense mobility of headgroup (sorbitol)
for Span 80 (Hayashi et a1., 20lI), water molecule was likely to be present at the deeper
region of vesicle membranes. This was probably because the sorbitol (headgroup) of
Span 80 in vesicle membranes could not prevent the water from its invasion into the
deeper region of membranes due to the weak dipole moment of sorbitol. As a
consequence, the dynamics at the interface of Span 80 vesicle could be kept at the high
extent level, as compared with that of DMPC liposomes (Fig. 1-5).
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4. Summary
' A surfactant vesicle is formed by the.assembly of molecule, resulting in the
induction of unique membrane properties. Membrane properties are dependent on the
lipid composition of the surfactant vesicle. An unsaturated phospholipid, POPC
molecule forms a liposome at liquid crystalline phase. POPC molecule dynamically
moves on the liposome membrane, resulting in the easy insertion of water molecules as
compared with DPPC liposome at gel phase. Span 80 molecules also forms Span 80
vesicle at liquid crystalline phase. The inner membrane properties of Span 80 vesicle are
similar to the POPC liposome. However, the headgroup mobility of Span 80 vesicle is
more intense than that of POPC liposome. The headgroup of POPC molecule with
permanent dipolar moment contributes to the electrical interaction of headgroup region.
On the other hand, Span 80 vesicle composed by non-ionic surfactant, Span 80
molecule. The headgroup interaction of Span 80 vesicle is lower than that of POPC
liposome. The headgroup mobility of Span 80 vesicle is not prevented by the headgroup
interaction as compared with POPC liposome. It is suggested that the low interaction of
the headgroup induces the dynamic membrane in the case of niosome (non-ionic
surfactant vesicle) like Span 80 vesicle. This dynamic membrane is expected to induce
the strong interaction with the plasma membrane. The characteization of membrane
properties contribute to the prediction of pharmacokinetics of the drug encapsulated
drug carrier (Fig. l-14).
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Chapter 2 Effect of Membrane Properties on Membrane-Membrane Interaction
1. Introduction
Recently, the "membrane-membrane" interaction has been assigned to several
kinds of steps. Considering the drug delivery system, the membrane of drug carrier,
such as surfactant and phospholipid vesicles, can bind to the biomembrane. Some
vesicles are intemalized via an endocytosis, as shown in Fig. 2-1. Other vesicles can
fuse with the biomembrane. Alternatively, the membrane properties affect not only their
interaction with the cells, but also the encapsulation efficiency of drugs. It has been
reported that the permeability of drugs from surfactant vesicle can be related with the
membrane fluidity of surfactant vesicle (Shimanouchi et al., 2009). It has been also
reported that there are various kinds of interactions between surfactant vesicle
membrane and drugs (Alves et al., 2011, Hao and Li,2011, Okamura and Yoshii, 2008).
Therefore, it is expected that the membrane properties could be related with the
retention capability of surfactant vesicle. In phenomenological studies, it has been found
that the lipid composition dominated the "membrane-membrane" interaction and the
"membrane-molecul e" interaction.
In contrast to the phenomenological investigations, the molecular mechanistic
Loading
vesicte(J o
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.'.@t
Fusion
lnternalization
Fig. 2-1 Possible interaction modes of membrane-membrane interaction
Lipid membrane
studies have been reported. To fully understand the 'omembrane-membrane" interaction
from the view point of oomolecule" and "niolecular assembly'', the interaction properties
have been characteized by using the variety of measurement methods, such as the
leakage of molecular probe or the fluorescence energy resonance transfer. Based on the
numerous reports, the binding of vesicle with the membrane can be assigned to a
membrane perturbation. The process of fusion has been discussed from the viewpoints
of lipid mixing/hemifusion. Among the possible surface properties, membrane fluidity
and hydrophobicity of the liposome has been reported to be a key factor to improve the
pharmacokinetic behaviors, such as the drug permeation (Komint et a1.,2006, Poste and
Papahadjopoulos, 1976, Uchiyama et a1., 1995), the binding of proteins to the liposomes
(Kuboi et al., 2004), and the fusion (Kuboi et al., 2000). Meanwhile, the relationship
between the phenomenological process of membrane-membrane interaction and the
molecular mechanism has been still unclear. By clarifying the above relationship, the
strategy of drug delivery system using surfactant-vesicles would become clear from the
view point of molecule.
In this chapter, the "membrane-membrane" interaction was investigated from
the viewpoints of (i) membrane perturbation, (ii) a lipid mixing/hemifusion, and (iii) a
diffusion of lipid on the membrane. In addition, considering the small molecule favoring
to distribute the lipid membrane as the alternative to the membrane, a distribution of
small materials into the vesicle was investigated. Finally, the possible predominating
factors for the interaction between membranes were elucidated from the results obtained
herein, together with the results with respect to the membrane propertied discussed in
chapter 1. The investigation performed herein would give the relationship between the
phenomenological process and the molecular mechanistic factor.
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2. Materials and Methods
2.1. Materials
Sorbitan monooleate (Span 80), polyoxyethylene sorbitan monooleate (TWeen
80), and doxorubicin hydrochloride (DOX), and ammonium surface were purchased
from Wako Pure Chemical lndustries (Osaka, Japao). Cholesterol, calcein, and
Triton@X-100 were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.).
Phospholipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) were purchased from the NOF
Corporation (Tokyo, Japan). 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitr-
o-2-1,3-benzoxadiazol-4-yl) (NBD-PE) and 1,2-dioleoyl-sn-glycero-3-phosphoethanol-
amine-N-(lissamine rhodamine B sulfonyl) (rhodamine-PE; (Rh-PE) was purchased
fromAvanti Polar lipids (Alabaster, AL, U.S.A.).
2.2. Prepzration of liposome
Phospholipids and cholesterol were dissolved in a chloroform solution. The
organic solvent was removed by evaporation in a rotary evaporator. The residual lipid
film, after dryrng under a vacuum ovemight, was hydrated with the inner-phase liquid
(155 mM (NH+)zSO+ or PBS; 137mM NaCl, 2-9mM KCl, 10mM Na2HPO4, 2rnNI
KHzPO+). The suspension was subjected to five cycles of freezing and thawing and then
extruded. The lipid concentration was determined by phosphorous analysis.
2.3. Preparation of Span 80 vesicle.
Span 80 vesicle was prepared by the two-step emulsification method (Kato et
aI.,2006).6 ml of n-hexane solution containing Span 80 and cholesterol was added to
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0.6 ml of inner-phase liquid (155mM (NH4)2SO4 or PBS), followed by the first
emulsification for 6 min at 17,500 rpm using a micio-homogenizer NS-310E 2
(Microtec Co., Ltd., Funabashi, Japan). The solvent obtained from the water-in-oil
emulsion was evaporated in a rotary evaporator at 28 oC under reduced pressure,
yielding a water-lipid emulsion to which 6 ml of outer-phase liquid (PBS) containing 96
mg of TWeen 80 was added, followed by mixing with the homogenizer for 2 min at
3,500 rpm to obtain the heterogeneous Span 80 vesicle suspension. The heterogeneous
vesicle suspension was stirred with a magnetic stirrer for 3 hours at room temperature,
followed by storage overnight at 4 oC. The vesicles were then purified by
ultracentrifugation (50,000 rpm at 4 oC for 120 min) in a Himac centrifuge CR15B
(Hitachi Koki Co., Ltd., Tokyo, Japan). The purified Span 80 suspension was passed
through 100-nm nucleopore track-etch polycarbonate membranes and purified twice by
ultracentrifugation (When Span 80 vesicle was prepared by (NH4)2SO4, Outer liquid
phase was exchanged from (NH+)zSO+ to PBS).
2.4.Calcein leakage
Calcein(100 mM)waS encapsulated into the liposome.The liposome(8.lμM)
was mixcd with Span 80 vcsicles(0.45 mM)at 37°C.When Span 80 vesicle could
interact with the liposomc membrane,the entrapped calcein is leaked from thc liposome,
resulting in the recovery of its fluorescencc fron■ the sel ―quenching statc
(B奮狙y―Walue et al.,2007)。At the cnd of thc above expcHment,Triton°X-100 was
added to this liposome suspension at the flnal conccntration of O.83 vo10/0,in order to
disrupt the structure of thc liposome completely. The perturbation effect of Span 80
vesicles on lipOsome was evaluated by the amount of calcein released, as described
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below:
RF is the fraction of calcein released. Io, It and I** are the fluorescence intensities
measured at the beginning of the experiment, at any incubation time t, and after the
Triton@X-100 addition to give a maximal fluorescence intensity, respectively.
2.5. Fluorescence resonance energy transfer (FRET) experiment
The liposome used for the FRET experiment was prepared by mixing 0.4 molo/o
NBD-PE and0.2moloh Rhodamine-PE. Afluorescence labeled liposome (1.5 mM) was
added to the Span 80 vesicle (25 mM). The alteration of the fluorescence of NBD and
Rhodamine (Rho) was observed with a fluorescence spectrophotometer, FP-6500
(JASCO Co., Tokyo, Japan) at 37 'C. Lipid mixing was evaluated by the energy transfer
efflrciency (ET), as described below:
ET : /nnoIrunr (2-2)
where 1p1e and .INeo indicate the fluorescence intensities at the respective emission, for
Rho-PE (58a nm) and NBD-PE (527 nm) after excitation at 472 nm. The percentage of
lipid mixing,o6BT, was calculated by the following equation:
RF=を11115
%ET=石曇}評登嵩
(2…
1)
(2-3)
where ETr indicates the transfer efficiency at arty incubation time / after vesicle mixing,
ETs refers to the vesicles just after mixing, and ET-u" is the value after the addition of
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Triton①X-100.
2.6. Laurdan monitoring
Hemifused vesicle: A hydrophobic fluorescence probe, Laurdan ( 1.0 pM), was added to
the liposome suspension (0.1 mM), and the mixed suspension was incubated for more
than 30 min. In another experiment, the Span 80 vesicle suspension was stepwisely
added as shown in Fig. 2-2. The ratio of lipid component used in this study is
summarized in Table 2-1.
Hemifused vesicle: Lipid mixing between Span 80 vesicle and POPC/cholesterol liposome
_」ゝ ゥト__>
POPC/cholesterol
liposome + Span 80 vesicles
Fig.2-2 Preparation method of hemifusion vesicle.
Table 2-1 Ratio of lipid composed in hemifused vesicle suspension.
Molar ratio [%]
Span 80 vesicles
suspension[μl]
0
200
400
600
800
1000
POPC     Cholesterol
750         250
62.5        20.8
536         17.9
46.9         156
41.7         139
37.5         12.5
Span 80
0.00
]-6 7
28.6
37.
44.4
50.0
PO PC/cholesterol liposome
45
Blended vesicle: POPC/cholesterol/Span 80 (37.5:12.5:50) were dissolved in
chloroform and were used for the preparation of vesicles by the thin film method (Fig.
2-3), as described before (2.2. Preparation of liposome), followed by incubation with
Laurdan (final concentration: 1.0 pM) for more than 30 min. The Laurdan fluorescence
spectra were measured with the fluorescence spectrophotometer FP-6500 (JASCO Co.,
Tokyo, Japan) at37 oC.
The Laurdan is the one of the environmentally-responsive fluorescence probe,
the fluorescence spectra of Laurdan show the distinct double peak at 440 nn and 490
nm by the difference of the polarization around the Laurdan molecule when Laurdan is
excited at340 nm (Parasassi et al., Igg4,Parasassi and Gratton, 1995). The Laurdan can
easily insert into the vesicular membrane, resulting in that the polarization of the
membrane can be evaluated by the GP1:+o; value indicating the difference of the double
peak at 440 nrn and 490 nm of the Laurdan.
(I++o-l+so)
(2-4)GP13+o) = (t44o+I4so)
laas: The fluorescence intensity of Laurdan at 440 rwt
lqqo: The fluorescence intensity of Laurdan at 490 nrrt
Blended vesicle: Preparation of Span 80/PO
PO PC/cholesterol/Spa n 80 vesicle
Preparation method of blended vesicle.
PC/chOlesterol vesicle
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Fig.2-3
2.T.Evaluation of the DOX encapsulation efliciency
DOX (0.5 mM) was mixed with the liposome suspension (inner phase:
(NFI+)zSO+) (5 mM) at 20 oC, 40 oC or 60 oC. After the incubation for each time (0 -
150 min), this suspension was added to the aliquot of NaOH solution. The DOX
solution could observe the absorption at 590 nm at the basic condition. The suspension
was measured the absorption at 590 nm, calculating the amount of DOX encapsulated
into the surfactant vesicle. A mass-transfer coefficient was calculated from the following
equation:
―字 Lut=S×Ⅳ
N=κ×偽ut
Co,,1: Concentration of the DOX in the outer phase [mo1'm-3]
Zoul: Total volume of vesicle [m3]
S: Total surface of vesicle [m2]
M Material flow rate [mo1'm-2's-l]
K: Mass-transfer coeffi cient [ttt' t-t ]
(2-5)
(2-6)
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3. Results and Discussion
3. 1. First Step of Membrane-Memb rane Interaction: 
. 
Membrane Perturbation.
In order to confirm the interaction between Span 80 vesicle and phospholipid
vesicle (liposome), the leakage of calcein entrapped inside the liposome was first
analyzed in the presence of excess of Span 80 vesicle in contrast to the target liposome.
In this experiment, the degree of the intensity of the interaction between the different
kinds of vesicles (Span 80 vesicle and liposome) could be monitored because the
leakage can be induced through the membrane perturbation caused by their interaction.
The perturbation of the liposome membrane after the addition of the Span 80 vesicle
was evaluated through the analysis of calcein leakage from the liposome. [a the first
series of experiments, the liposome encapsulating the calcein (liposome IAI) (a
simplified model of plasma membrane) and the vesicle [B] (a drug carrier) were
prepared as schematically shown in Fig. 2-a@). Figure 2-4 and Table 2-2 show the
time course of the calcein leakage from the liposome IAI (RF value), induced by the
addition of vesicle [B]. The addition of Span 80 vesicle (vesicle [B]) to DPPC liposome
(liposome [A]) immediately induced a significant increase in the RF value, indicating
that almost all the calcein was leaked from the DPPC liposomes. It is considered that
this is caused by the strong interaction of the Span 80 vesicle with the DPPC liposome
membrane. Furthermore, a similar tendency for the RF value was also observed in the
case of POPC or POPCicholesterol liposome (Figs. 2-4(b) and (c)). It was thus
demonstrated that the Span 80 vesicle could perturb the membrane of all kinds of
liposomes tested here.
The Span 80 vesicle used as a vesicle [B] was replaced by phospholipid
vesicles in order to confirm the possible interaction between different liposomes
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Fig. 2-4 Calcein leakage from liposome, caused by Span 80 vesicle. (a) Calcein
encapsulating liposome (liposome [Al) was added to Span 80 vesicle (vesicle
[B]), and the membrane interaction was evaluated from the amount of calcein
leakage. (b) Calcein was leaked from liposome [A] (DPPC or POPC) by adding
vesicle [B] (Span 80 or POPC), or (c) from liposome [A] (POPC/cholesterol) by
adding vesicle [Bl (Span 80 or POPC). The molar ration of POPC/cholesterol
and Span80/cholesterol was set at 75 : 25 and at 67 : 33, respectively.
Abbreviation: ch. cholesterol
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POPC
Span 80/ch
Span80
themselves. [n contrast to the case of Span 80 vesicle, no increase in the RF value was
observed when the POPC liposome was used as vesicle [Bl and was mixed with DPPC
liposome as liposome tAl (Fig. 2-a@)). The same was true for POPC/cholesterol
liposome used as liposome tAl (Fig. 2-a@). The above results indicate that the POPC
liposome cannot induce the perturbation in other kinds of liposome membrane, in
contrast to the Span 80 vesicles.
When the Span 80 vesicle was used as vesicle [B], the calcein leakage from
POPC or POPC/cholesterol liposome was less than that from DPPC liposome (Figs.
2-3(b) and (c)). The above results imply that the calcein leakage from liposome [A] can
be correlated with the phase state of liposome tAl (Fig. 2-5). The phospholipid
molecules have been previously reported to be tightly anayed on the membrane in the
case of DPPC liposome at gel phase liposome (Koynova and Caffrey, 1998). The
liposome membrane at the gel phase is also known to be hard as compared with that at
the liquid crystalline phase (Shimanouchi et a1.,2009).It has been reported that the tight
phospholipid array is hence disturbed by the insertion of the extra lipids such as
cholesterol (lpsen et al., 1987). Some researchers have reported that the low flexibility
of the DPPC inhibits the construction of the hard membrane when DPPC is mixed with
??
﹈?
「
?
??
POPC
Low
Low
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Table 2-2 Calcein leakage from liposome [a] by adding vesicle [B].
Abbreviation : ch. cholesterol
Liposome [A]
POPC/Ch
Low
Low
???
??
?
other lipids on membrane (Alipour et al., 2008, Carrillo et al., 2003). The observed
leakage of almost all calcein from DPPC liposome after the addition of Span 80 vesicle
could be related with the previous finding that Span 80 vesicle disrupted the tight
phospholipid array and inhibited the reconstruction of hard membrane of the DPPC
liposome. On the other hand, the phospholipids array of the POPC or POPC/cholesterol
liposome is not so tight as compared with that of the gel phase liposome (Kolmova and
Caffrey, 1998, Thewalt and Bloom, 1992), indicating that the membrane of the POPC or
POPC/cholesterol liposome is rather "fluid' than "hart' (Shimanouchi et al., 2009).
The leakage of the calcein from POPC or POPC/cholesterol liposome was inhibited by
the flexible membrane reconstruction of liposomal membrane when Span 80 vesicle
interacted with liposome.
DPPC liposome
(Gel phase)
POPC liposome
(Liquid crystal phase)
O CC
Fig. 2-5 Schematic illustration of the interaction between Span 80 vesicle and
liposomes. The amount of calcein leakage from DPPC liposome is more than
that from POPC liposome.
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The observed difference between the Span8O vesicle and POPC liposome can
be caused by the "flexible- nature on the Sian 80 vesicle (Chapter 1). The headgroup '
of phosphatidylcholine as a component of the liposome membrane possesses a dipole
moment, with both a positively charged group (N--(CHr):) and a negatively charged
one (-PO+--), which provide a relatively strong electrostatic interaction between
phosphatidylcholine molecules (Shimanouchi et al., 20Il). This interaction at the
membrane surface can restrict the interaction with the membrane of the apposed
liposomes. In contrast to the phosphatidylcholine, the headgroup of Span 80 is sorbitol
that has no pennanent dipole moment, implying that the interaction between the
headgroup of Span 80 is relatively weak. The larger value in the calcein leakage after
the addition of Span 80 vesicle might be caused by the larger mobility of the headgroup
of Span 80 in contrast to phospholipid. This opinion is also supported by Fig. 2-4(d).
Figure 2-4(d) shows the strong interaction between Span 8O/cholesterol vesicle and
liposome. It has been already reported that the addition of cholesterol reduced the inner
membrane fluidity of Span 80 vesicle. However, it did not affect the headgroup mobility
of Span 80 vesicle (Chapter 1). It is concluded that the larger mobility of the
headgroup of Span 80 vesicle is the key factor for interaction with liposome.
In order to discuss the general relationship, the calcein leakage from liposome
[Al is plotted against its headgroup mobility (Fig. 2-6(a)). In the case of low mobility of
the headgroup of lipids in vesicle [B] (< 60 MHz), no calcein leakage from the
liposome [A] was induced despite the variation of the mobility of liposome [Al. In
contrast, the vesicle [B] with high mobility (> 200 MHz) could induce the calcein
leakage from the liposome [Al. The critical mobility of liposome [Al can be observed
at 30 MHz. Altematively, the calcein leakage from liposome [Al is plotted against the
52
(b)
﹇‐】???〓?????
??
?
【‐】???〓???〓?
??
?
Phase separation
Gel phas I l-lquid crystal phas
50
カ[MHZ]
(Region l)  〔Region 2)   (Region 3)
Liposome[A]
◆DPPC
□POPC/cho
▲PoPc
????
Veside[B]
SnanRO/rho SnanR0
rcr[MHz]
(C)
?
‐
_4-‐‐
?‐】???〓?????
??
?
2  3 4 56789
fc′[B]/」criA][―]
Fig. 2-6 Relationship between calcein leakage and headgroup mobility of (a) liposome
[Al, and (b) vesicle IBl. (c) The calcein leakage was systematically analyzed
according to the ratio headgroup mobility betrveen liposome [Al (f,; [A]) and
vesicle IBI (,,f",[B]). Abbreviation: ch, cholesterol
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headgroup mobility of vesicle [B], as shown in Fig. 2-4(b). Below the critical
headgroup mobility of liposome [Al,.an increase in headgroup mobility of vesicle [B]
induced no remarkable increase in calcein leakage. Meanwhile, an increase in calcein
leakage was observed in the case of the critical headgroup mobility of liposome [A].
These results suggest that the stiff lipid membrane was subject to be perturbed by its
interaction with membrane possessing on interface with high mobility. Moreover, this
relationship was shown in Fig. 2-6(c) according to the ratio of headgroup mobility
(liposome lAl: f"i [A], vesicle IBI: "f"t[B]). These plots were categorized into three kinds
of region (Region l: <2, Region 2:2-6, Region 3: > 6). [n region 1, the calcein leakage
from liposome [A] was not observed, resulting in the lower interaction between
liposome [A] and vesicle [Bl. In region 2, the calcein leakage from liposome [A] was
observed, resulting in the adequate interaction between liposome [A] and vesicle [Bl. In
region 3, almost all calcein was leaked from liposome [A], resulting in the strong
interaction between these vesicles. It is suggested that the ratio of headgroup mobility
determines the interaction intensitv.
These results ur. n.r.*nn assumed to be caused by the "difference" of the
properties of two membranes as schematically shown in Fig.2-7.h chapter 1, it has
been clarified that the membrane property can reflect the molecular behaviors of
membrane component. After the different membranes can be contacted with each other,
the difference of the molecular behaviors can be a driving force to trigger the next step
of the "membrane-related phenomena", such as membrane perturbation, lipid mixing,
and membrane fusion. In order to confirm the above assumption, the differences in
membrane properties were plotted against the calcein leakage as shown in Fig. 2-8. The
differences in membrane fluidity, head group mobility and polarity are herewith
54
The "difference" the properties
oftwo membranes
Liposome [A] Vesicle[B]
Fig.2-T "Difference" the properties of two membranes induce the
"membrane-rel ated phenomena".
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Fig. 2-8 Relationship between calcein leakage and differences in *.rnfrun. properties,
(a) fluid, (b) flexible, and (c) wet.
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calculated from the following equation;
Membrane fluidity: zt/ p 
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ln case of membrane fluidity and head group mobility the increase of both /llp and
Z krt, was found to induce ihe calcein leakage from liposome [Al. Instead, the
decrease of Z GPlr+o;was found to induce the calcein leakage from liposome [Al. A
threshold was observed in all cases (Z tlP:5.5, Z lnf"i: 1.8, Z GPp+01:3.5).
The above results show that the membrane-membrane interaction was induced
especially when the value of difference of membrane properties between two
membranes (called as oomembrane potential") was overpassed above the threshold of the
differences in membrane properties. It was thus found that the oomembrane potential"
could be a key factor to explain the membrane-related phenomena.
3.2. Second Step of Membrane-Membrane Interaction: Lipid Mixing and
Hemifusion.
ln the previous section, the membrane perturbation process for membrane
fusion was shown to be governed by the membrane properties. Among the possible
phenomena related to membrane, a lipid mixing can be a promising one as a next step of
the perturbation. In general, the degree in the decreased efficiency of
proximity-dependent fluorescence resonance energy transfer (FRET) has been
considered to be correlated with lipid mixing (Marsden et aI.,20Il, Struck et al., 1981).
A liposome incorporating two different fluorescence-labeled lipids has been used to
evaluate the efficiency of FRET between them (%ET), which is a quantitative index for
the lipid mixing. In this section, the interaction between liposome [A] and vesicle [B] is
discussed in terms of %ET value, by using the liposome [A] labeled with both NBD-PE
and Rho-PE (Fig. 2-9(a)). When the Span 80 vesicle was used as vesicle [Bl, the %ET
value for the DPPC liposome as liposome [Al increased after the addition of the Span
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Fig. 2-9 Lipid mixing between Span 80 vesicle and liposome. (a) Span 80 vesicle
(vesicle [B]) was added to fluorescence labeled liposome (liposome [A]), and
lipid mixing was evaluated by FRET method. (b) Lipid mixing of liposome [A]
by adding vesicle tBl. (c) Comparison of lipid mixing: right seconds after mixing
vesicle, and 30 min later. Mean values (+ standard deviation) are given for
measurements carried out with 3 times. The molar ration of POPC/cholesterol
and Span80/cholesterol was 75 : 25 and 67 : 33, respectively. Abbreviation:
ch. cholesterol
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80 vesicle (Fig. 2-9(b)). The YoET value after 30 min was consequently increased as
compared with that aftei mixing (Fig. 2-9(c)). The %ET value for the POPC or
POPC/cholesterol liposome as liposome [Al also increased just after adding the Span
80 vesicle (Fig. 2-9(b)), while the o/oET value after 30 min was not consequently
increased as compared with that after mixing (Fig. 2-9(c)). A11 kinds of liposomes and
Span 80 vesicle immediately interact with each other as shown in Fig. 2-4 (Calcein was
immediately leaked from liposome after the addition of Span 80 vesicle), while the
speed of the lipid mixing was dominated by the phase state of liposome (Liposome [A])
(i.e. The diffusion speed of Span 80 molecule is slower at DPPC liposome as compared
with POPC or POPC/cholesterol liposome). The difference of the increasing speed of
theo/oET (ipid mixing) value attributed to the membrane fluidity. The membrane of the
liposome at liquid crystalline phase (POPC or POPC/cholesterol liposome) is
highly-fluided, resulting in fast increase of the %ET value. The liposome at gel phase
(DPPC liposome) has the lower fluidity, resulting in slow increase of the o/oET value as
compared with that at liquid crystalline phase. On the other hand, the POPC liposome as
vesicle [Bl was used instead of Span 80 vesicle. After the POPC liposome (vesicle [B])
was mixed with DPPC liposomes (liposome [A]), the YoET value decreased from 0.44
to 0.1 in contrast to the case of the mixture of DPPC (liposome [A]) with Span 80
(vesicle tBl) (Fig. 2-9(c)). It is therefore considered that the abnormal properties of
Span 80 vesicle, such as flexible surface and molecular structure of lipids, are important
to increase the%oET value.
When cholesterol is incorporated into the Span 80 vesicle, the lateral diffirsion
of Span 80 in the membrane can be reduced, while keeping the intense mobility of the
headgroup of the Span 80 (Chapter 1). The Span 80icholesterol vesicle was herein used
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as vesicle [B], in order to examine the significance of headgroup mobility throughout
the interaction between vesicles. The %ET value increased to 0.2 - 0.4 in the case of
DPPC, POPC, and POPCicholesterol as liposome [Al (Fig. 2-9O)). It was thus found
that the Span 80/cholesterol vesicle could promote the energy transfer between lipids in
the membrane of the liposome [A].
In order to discuss the effect of headgroup mobility, the lipid mixing ratio was
plotted against the headgroup mobility of liposome [A] (Fig. 2-10(a). Vesicle [B] with
low headgroup mobility induced no lipid mixing against liposome [Al. In contrast, the
vesicle [Bl with high headgroup mobility could induce the lipid mixing and a significant
increase in lipid mixing in the range of headgroup mobility below 45 MHz. As well as
the calcein leakage, it is considered that there existed the critical headgroup mobility in
the induction of lipid mixing. Based on the results in Fig. 2-10(a), the critical headgroup
mobility was set to 45 MHz. Next, the effect of vesicle [B] on lipid mixing was then
discussed based on Fig. 2-10(b). Below the critical headgroup mobility, the lipid mixing
was gradually induced. Above the critical headgroup mobility, the effective increase in
lipid mixing was induced. Furthermore, the lipid mixing was plotted against the
membrane fluidity as shown in Fig. 2-10(c), the membrane fluidity of liposome [A] is
related with the lipid mixing within seconds after mixing. This suggests that the lipid
mixing requires the intense headgroup mobility and the lateral diffusion.
Similarly in the case of section 3.1 (Fig. 2-7 and Fig. 2-8), the value of the lipid
mixing between two vesicle membranes was also plotted against the oomembrane
potentials", defined as Eq (2-7) 
- 
(2-9), as shown in Fig. 11. In the case of membrane
fluidity, the increase of each /ttp was found to induce the lipid mixing in liposome
tAl (Fig. 2-10 (a)). On the contrary, the decreas e of ZGp(340) was found to induce the
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lipid mixing in liposome [A] (Fig. 2-10 (c)). A threshold was observed in both cases
(Z llP: 5.5, / lnf"i: 1.8, / GPpaol: 3.5). A clear dependence of the lipid mixing
on the / lnf"i was observed as shown in Fig. 2-10(b). The above results show that the
lipid mixing, followed by membrane perturbation, can be strongly dependent on the
molecular motion of the membrane.
3.3. Effect of the Diffusion of Span 80 vesicle/molecule on the liposome
membrane.
lt was examined whether the Span 80 vesicle could alter the polarity of the
liposome membrane by lipid mixing. A hemifused vesicle was first prepared by mixing
Span 80 vesicle with POPC/cholesterol (75:25 in molar ration) for 30 min of incubation
(Fig. 2-2). POPC/cholesterol/Span 80 vesicle (37.5: I2.5: 50 in molar ration) was also
prepared as ideally hemifused vesicles (blended vesicles) (Fig. 2-3). The membrane
polarity of the hemifused vesicle was compared with that of the blended vesicle. The
fluorescence spectra for the Laurdan-embedded POPC/cholesterol liposome are shown
ん>2∞
・   島く60
Fluid(Z11/P)[―l Flexible (Z Inf.,) [-]
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in Fig. 2-12(a). A peak derived from in nonpolar environment was observed at around
440 nn (curvb: 0 pl). The addition 'of Span 80 vesicle resulted in the increase of the
peak derived from in polar environment around 490 nm (curves: 400 and 800p1),
together with the decrease of the peak derived from in nonpolar environment around
440 nn (Parasassi et aI., 1998). In order to quantitatively monitor the variation in the
polar environment of the membrane, the GPlr+o; value was estimated from the observed
spectra according to the literature (Parasassi et al., 1994), and was plotted against of the
molar ratio of Span 80, as shown in Fig. 2-12(b). The GP1:+o; value linearly decreased
with the increase in the ratio of Span 80, which was compatible with the presence of an
isosbestic point at around 470 nn, as observed in Fig. 2-11(a), and with the finding of
GPt:+ot (Span 80) < GP1:+o; @OPC/cholesterol). These results suggest that the variation
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Fig. 2-12 Alteration of liposomal membrane property by Span 80 vesicle. (a)
Fluorescence spectra of Laurdan after adding Span 80 vesicle by 0 to 1000
pl in volume. (b) The relationship between the GP1:+o; value and the ratio of
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of the polar environment of the vesicle membranes is related with the interaction
between vesicles.
In addition, the variation in the polar environment of the hemifused vesicle
was compared with that of the blended vesicle prepared as ideal hemifused vesicle.
The fluorescence spectra of the Laurdan bedded in the membrane of the Span
80/POPC/cholesterol vesicle (blended vesicle) was slightly different from those of the
hemifused vesicle (Fig. 2-13(a)). The GPr:aol value for the hemifusion vesicle was
higher than that of the blended vesicle (Fig. 2-13(b)). From the experiments using
Laurdan, it can be concluded that the Span 80 vesicle did not considerably hemifuse
with the POPC/cholesterol liposome, though some of Span 80 vesicle slightly hemifuse
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Fig. 2-13 Composition of membrane polarity between hemifused vesicle and blended
vesicle (a) Fluorescence spectra of laurdan for Span 80 vesicle, POPC/cholesterol
liposome, hemifused vesicle, and blended vesicle. Blended vesicle is the vesicle
composed of POPC, cholesterol, and Span 80. (b) The comparison of the GPlt+o;
value for the hemifused vesicle and that of the blended vesicle.
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with themselves. However, Span 80 vesicle hemifuses with liposome at large extent
enough to alter the polarity of ihe liposome membranb. These results are also supported
by the hemifusion between Span 80 vesicle and liposome.
In order to discuss the mechanism underlying in vesicle-vesicle interaction
phenomena, the lipid mixing of various vesicles was compared with the calcein leakage.
As shown in Fig. 2-14, biphasic trend was observed in their relationship. First, a
significant increase in lipid mixing was induced by the small incremental change in
calcein leakage. The calcein leakage requires the defect on the lipid membrane, so that
calcein pass through there. It is therefore considered that the membrane perturbation of
stable lipid membrane due to the outer environmental condition could give the space for
lipid molecules to diffuse laterally. In contrast, in the high calcein leakage region, the
gradual increase of lipid mixing was observed. This is because there is a considerable
Calcein leakage [-l
Fig.2-14 Relationship between calcein leakage and lipid mixing.
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space for lateral diffusion of lipid molecule under the condition of high calcein leakage.
From the above.consideration, it is suggested that the memtjrane perturbation (calcein
leakage) was followed by the lipid mixing, which is consistent with the time
dependency of both calcein leakage (-10 sec, Fig. 2-4) and lipid mixing (-30 min, Fig.
2-9). However, it is not meant that the intense promotion of lipid mixing induce the
perfect fusion of vesicles because Fig. 2-15 suggests the hemifusion as a possible
mechanism. Therefore, the relationship between membrane perturbation and lipid
mixing, as the hemifusion process, will be discussed in the following.
(a)
Mono-ester Di-ester Tri-ester
▽he・d∞∝ 国C力nder △  cOne
(b)
Span 80
vesicle
Hemlfuslon
叫
Stalk interrnediate
ヽ
Fig. 2-15 Possible scheme of hemifusion model via Stalk intermediate. (a) Span 80
vesicle contain some kinds of esters, such as mono-, di-, and tri-ester. The
relative size of the headgroup and the acyl chain region is relatively
different. The shapes of mono-, di-, and tri-ester are likely to be inverted
cone, cylinder and cone structure, respectively. (b) Hemifusion process.
Cone-shaped lipids are able to form a stalk intermediate with negative
curyature.
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The membrane perturbation is the initiating factor for hemifusion process. From
th6 results obtained before, the Span 80 vesicie is a promising system to induce the
membrane perturbation. In addition, the molecular mobility of lipid in membrane would
depend on the structure of lipid molecule. Therefore, hemifusion model will be
discussed by exemplifyrng Span 80 vesicle. It has been reported that Span 80 vesicle
contains mono-ester, di-ester, and tri-ester (Kato et dI., 2006). Based on
previously-reported definition (Chernomordik and Kozlov, 2008), mono-ester, di-ester,
and tri-ester corespond with an inverted cone structure, a cylinder structure, and a cone
structure, respectively (Fig. 2-15(a)). It is suggested that the mono-ester in Span 80
vesicle can form a point-like protrusion, which can tlpically be observed in the case of
inverted cone-shaped lysophosphatidylcholine (Chernomordik and Kozlov, 2008). The
point-like protrusion has been reported to promote the membrane interaction as the first
step of the fusion (i.e. the point-like protrusion insert into the apposed membrane) (Efrat
et a1., 2007), suggesting that the mono-ester in Span 80 vesicle is also an important
factor to interact with liposome.
It is also suggested that the structure of lipid in Span 80 vesicle is important to
understand the hemifusion between Span 80 vesicle and liposome. In general, vesicle
associates to form the stalk intermediate, which is also known as hemifusion model
(Chemomordik and Kozlov, 2008, Hafez and Cullis,200l, Siegel, 1999). In the
associated region of different vesicles, lipid membranes deform to a bilayer membrane
structure, as shown in the zoomed frame of Fig. 2-15(b). In the process of hemifusion,
the geometric structure of the lipid (e.g., inverted cone, cylinder, cone (Fig. 2-15(a)) is
important, as well as the lipid mixing. Especially, a lipid with a cone structure is useful
for the generation of a negative curvature, which can contribute to the formation of the
66
stalk intemediateo When a s″ル 加′θ
“
ヮθ″′αた is fo.Шed,the lipids in the liposome
dilttse inito■e Span 80 veside,a process which is cdled lipid mixi屯.ThiS iS
compatible with ttЮob ttned result on a hiま0/OET valuc h Span 80 vesicle/DPPC
lipoSome system KFig。2‐9o)).
3.4. ]Design of the Surfactant‐v sicle Membrane for the Efflcient Drug
Ca2psulation in to the Drllg C田亘er Based on the Membrane PolaⅢ.
The efLct ofmembrane properties was mvestigated,focusmg on the membrane
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1995)The remOte loading of DOX was perfo.Щed by the transmembrane pH gradient
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Doxoru bici n hydroch lorjde (DOX)
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Fig. 2-16 Encapsulation mechanism of DOX. DOX inserts into the membrane dependent
on the hydrophobioity.
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sulfate), followed by adding a more basic solution to raise the pH of extemal solution
pH (PBS). When DOX molecule passes through the surfactant v'esicle membrane, DOX
molecule becomes protonated intravesiculary in the inner phase at low pH. The
positively charged DOX is difficult to pass the bilayer, resulting in the trapping of DOX
into the inner aqueous phase of surfactant vesicle.
Lr the first series of experiments, the time course of DOX present at the external
aqueous phase of liposome was monitored to estimate the mass transfer coefficient,
according to Section 2-9. The obtained mass transfer coefficient was summarized in
Table 2-3. Overall, the order of mass transfer coefficient was 10-7 - 10-6 m/s under the
temperature condition of 60 "C. DPPc/cholesterol liposome gave the maximal mass
transfer coefficient. Based on the previous finding that the permeation coefficient of
calcein could be correlated with the membrane fluidity (Shimanouchi et al., 2009),
DOPC or DMPC liposomes should give the higher mass transfer coefficient than DPPC
liposome. Then, to reveal the above ambiguous feature, the mass transfer coefficient
was compared with the physiochemical property of membranes.
Table 2-3 Relationship between GP1:+ol values and mass-transfer coefficient. These
liposome were evaluatedat 60'C
Lipid mixture GPl3aey value
t-I
Mass―transfercoefficient
im/S]
DLPC(12:O PC)
DMPC(14:O PC)
DPPC(16:O PC)
DPPC:ch(9:1)
‐0.220
-0.154
-0.115
-0.024
7.02X10‐10
1.06X10‐9
2.25X10‐9
1.35X10‐6
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The relationship between GPlraoy value and mass-transfer coefficient at 60 "C
was summaized in Table 2-3. Considering the GPt:+ot value (Parasassi et al., 1994) alrtd
previous report (Koynova and Caffrey, 1998), these liposome have membrane at liquid
crystalline phase at 60 oC (Liquid crystalline phase: GP1:+oy < -0.3, Gel phase: GP(:+o) >
-0.3). The increase of GPtraot value increased the accelerated-mass-transfer coefficient.
In order to investigate the relationship between GPts+o) values and mass-transfer
coefficient in detail, the above experiment was also carried out at lower temperature
(20 'C or 40 oC). These results are plotted in Fig. 2-17. In the case of liposome at liquid
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Fig.2-I7 Effect of membrane polarity and fluidity for the mess-transfer coefficient.
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crystalline phase (liquid crystalline phase: GP(r+o) < -0.3), the increase of GP1:noy value
increased the accelerated-mass-transfer coefficient, being independent of temperature.
On the other hand, the mass-transfer coefficient was decreased in match with the
increase of GPll+oy value in the range of GP1:ao; > -0.3 (Gel phase).
These results suggest that the mass-transfer coefficient is dependent on the
membrane polarity. DOX is hydrophobic molecule (logP'ocr:l.4ln-octanoV p}J7.4 buffer
solutionl), suggesting the easier distribution the hydrophobic phase. In addition, in the
range of GPllao; < -0.3 (Liquid crystalline phase), the vesicle has the higher membrane
fluidity (Table 2-3). The membrane with high fluidity can afford the space not only for
lipid molecule to laterally diffrrse on the membrane but also for DOX to distribute into
membranes. Such a space on the lipid membrane should give the hydrophobic
environment. Therefore, the hydrophobicity of the membrane contributed to the
insertion of DOX into the membrane in the case of liquid crystalline phase. However,
the increase of the GP1:+o; value was coffespond with the decrease of the mass-transfer
coefficient in the case of gel phase. Overall, these liposomes had the low membrane
fluidity. The phospholipid molecules are therefore tightly arrayed on the membrane at
gel phase (Koynova and Caffrey, 1998), suggesting that the tightly arrayed of
phospholipid molecules inhibit the insertion of not only water molecule, but also DOX.
Therefore, it is likely that the hydrophobic membrane at liquid crystalline phase could
effectively encapsulate DOX.
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4. Summary
From the exferiments of the calceiir leakage and the FRET method, it has been
demonstrated that the Span 80 vesicle with intense headgroup mobility as a possible
drug carrier can easily interact with the liposome as a model cell membrane. There are
three steps during the interaction between different vesicles, such as perturbation,
hemifusion, and fusion which is the final step of the interaction of the o'hetero"-vesicle.
Span 80 vesicle aggregates (calcein leakage), and hemifuses (FRET method) with
liposome, though further investigation on the fusion between Span 80 vesicle and
liposome is needed (the aqueous content mixing assay) (Kato et a1., 2008). As an
interaction mechanism, it is revealed that the difference of membrane properties
(especially, head group mobility) between vesicles (called as o'membrane potential")
and lipid structure (Lrverted cone structure) in Span 80 vesicle can act as the trigger for
the interaction between vesicles (Section 3.1), which is advantageous for the
enhancement of the lipid mixing process (Section 3.2). The membrane-membrane
interaction (membrane perturbation, and lipid mixing) was strongly induced when the
value of 'omembrane potential" of "fluid' "flexible" and"wet" was large. It is necessary
that the value of "membrane potential" was overpassed the threshold of the differences
in membrane properties. The increase of Z llP ("fluit') and Z lnf"i ("flexible"),
andlor the decrease of Z GPll+oy ("wet") induce the membrane-membrane interaction.
Although, the relationship between membrane-membrane interaction and "membrane
potential" has not been clarified in terms of molecule level, this relationship is
important to completely understand the mechanism of membrane-membrane interaction.
After the interaction between Span 80 vesicle and apposed vesicle, resulting in the
alteration of their membrane properties (Section 3.3). The above phenomena were
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different from the case of the ideal hemifused vesicle, suggesting the existence
uncompleted hemifusion in the case of Span 80 - lipbsome system. It was also observed
that Span 80 vesicle could hemifuse with liposomal membranes without the use of
fusogenic proteins (e.g. SNARE protein (Martens and McMahon, 2008) ). While the
liposome differs from the plasma membrane from the view point of the lipid component,
diameter size, curvature, and existence of scaffold protein, these results are helpful to
clarify the drug delivery mechanism of Span 80 vesicle and are useful for the further
development of Span 80 vesicle as drug carriers.
Encapsulation efficiency of DOX was controlled by the membrane polarity
(Section 3.4.). The hydrophobicity of DOX improves the insertion of DOX into the
surfactant vesicle surface by the hydrophobic interaction. Therefore, more hydrophobic
membrane effectively recruits DOX into the surfactant vesicle. However, it is difficult
for DOX to be inserted into the surfactant membrane at gel phase, in spite that
surfactant membrane at gel phase is more hydrophobic than that at liquid crystalline
phase. Tight array of surfactant molecules on the membrane can inhibit the insertion of
DOX into the msmbrane. These results suggest that the moderate membrane dynamics
and hydrophobicity of the surfactant vesicle are needed for the effective encapsulation
of DOX into the surfactant vesicle.
The interaction with the membrane (membrane-membrane or membrane-drug)
is intricately related with the membrane properties, "fluit', "flexible", and oowet". It is
expected that these interaction can be controlled by the design of drug carrier based on
these membrane properties. ln relation to Span 80 vesicle, Span 80 vesicle with intense
headgroup mobility easily interacts with the lipid membrane like a plasma membrane.
However, the dynamic membrane of Span 80 vesicle allows the insertion of the water
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molecule into the Span 80 vesicle membrane, resulting in the hydrophilic membrane. It
is disadvantagci for the encapsulation of DOX by remote loading method. Choledterol
insertion into the Span 80 vesicle does not affect the headgroup mobility of Span 80
vesicle, while the increases the hydrophilicity of the Span 80 vesicle membrane.
Therefore, Span 80 vesicle can efficiently encapsulate the DOX by remote loading
method, with keeping the higher interaction activity for the lipid membrane by insertion
of cholesterol into the Span 80 vesicle membrane.
Form the obtained results. the interaction between membranes
(binding/internalization/fusion) could be separated to each fundamental step: (i) a
membrane perturbation; (ii) a lipid mixing/hemifusion; (iii) a diffusion of lipids on
apposed membranes, as shown in Fig. 2-18.
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Chapter 3 Control of Membrane-Membrane Interaction between Vesicle and Cell
Iiased on Membrane Properties
L.Introduction
'oMembrane-membrane" interaction is dependent on the membrane properties.
As described in previous chapter, Span 80 vesicle with the intense mobility of its
headgroup easily binds to the liposome membrane and also perturbs the surface of the
liposome. Liposome has been conventionally employed as a model of plasma
membrane, although the plasma membrane is more complex than liposome. The plasma
membrane is composed by various lipids (phospholipid, cholesterol, sphingolipid, etc),
containing membrane proteins and "raft" strucfure. Therefore, the expected
"membrane-membrane" interaction based on the membrane properties (Chapter 1) (e.c.
Fusion between Span 80 vesicle and plasma membrane) could be important factor to
control the interaction of surfactant vesicle with the membrane of biological cells.
The pattern of "membrane-membrane" interaction can affect the drug delivery
efficiency. Most anti-tumor drugs are designed and developed to target the nucleus. The
anti-tumor drug is, for example, inserted into the double strand of DNA, inhibiting the
DNA synthesis and cell division of cancer cells. ln order to inhibit the proliferation of
cancer cells, an anti-tumor drug is needed to pass through the plasma membrane and
nuclear membrane. Drugs encapsulated into liposome are usually uptaken by
endocytosis into the cytoplasm, in some cases, resulting in the elimination the
encapsulated drug by exocytosis from biological cells. Therefore, it seems that the
"membrane fusion" is one of the most effective drug delivery pathways to directly
deriver the drug into the cytoplasm without the escape from exocytosis mechanism.
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The contribution of membrane properties for the oomembrane-membrane"
interactioh was investigated in this caption by using cahcer cells as atarget. The scheme
of the design of drug carrier was established based on the membrane characteization as
described in detail in results and discussion section. The first step of the interaction
between drug carrier and plasma membrane is contributed by the headgroup mobility.
The surfactant vesicle with high-intense headgroup mobility can easily fuse with the
plasma membrane. In the case of the surfactant vesicle with high fluidity, the surfactant
diffrrses on the plasma membrane after the fusion with the plasma membrane. The
diffirsing surfactant on the plasma membrane alters the membrane properties of the
plasma membrane, resulting in the cell death at an appropriate condition. The
cytotoxicity of the fusing surfactant vesicle is dependent on the type of the cell line or
applied dose. The control of the cytotoxicity of the fusing sur ctant vesicle enables us
to develop a novel drug delivery targeting an intracellular organelle by using
vesicle-in-vesicle system, as described below. Moreoveq the surface of the surfactant
vesicle is capable of the modification of the substance, such as antibody (Kesharwani et
a1.,2012). These proteins can specifically bind to cancer cells. There is a difference in
the plasma membrane surface between normal cells and cancer cells. It has been
reported that the epidermal growth factor receptor (EGFR) (Thomas, 2003), or folic acid
receptor (Ross et al., 1994) are more displayed on the plasma membrane of the cancer
cells as compared with the normal cells. The anti-EGFR antibody or folic acid are
applicable for the active targeting by the modification for the surface of the surfactant
vesicle (Kesharwani et al., 2012, Ross et al.,1994). While it is important to understand
the binding mechanism between cancer cells and the surfactant vesicle modified with
substance (anti-EGFR antibody or folic acid), the mechanism has not been clarified in
75
detail. It is expected that membrane charucteization could contribute to the
understanding of ihe behavior on the m6mbrane, such as protein-protein interaction on
the membrane. The feature of the plasma membrane of cancer cells also helps to design
the drug carrier. The lipid composition of plasma membrane and expression of the
plasma protein are different from cancer cells and normal cells. After the investigation
using a design scheme to control the o'membrane-membrane" interaction based on
o'membrane properties", some kinds of drug delivery systems were proposed as a case
study of proposed scheme.
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2. Materials and Methods
2.1,. Materials
Sorbitan monooleate (Span 80), polyoxyethylene sorbitan monooleate (Tween
80), and doxorubicin hydrochloride (DOX), and ammonium surface were purchased
from Wako Pure Chemical Industries (Osaka, Japan). Cholesterol was obtained from
Sigma-Aldrich (St. Louis, MO, USA). Phospholipids such as 1-palmitoyl-2-oleoyl-sn-g-
lycero-3-phosphocholine (POPC) and I,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) were purchased from the NOF Corporation (Tokyo, Japan). 1,2-dioleoyl-sn-gly-
cero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (rhodamine-PE;
(Rh-PE)) was purchased fromAvanti Polar lipids (Alabaster, AL, USA).
2.2. Pr eparation of liposome
Phospholipids and cholesterol were dissolved in a chloroform solution. The
organic solvent was removed by evaporation in a rotary evaporator. The residual lipid
film, after drying under a vacuum overnight, was hydrated with the inner-phase liquid
(155 mM CNH4)2SO4 or PBS; 137mM NaCl, 2-9mM KCl, 10mM NazHPO+, 2mM
KHzPO+; pH 7.3). The suspension was subjected to five cycles of freezing and thawing
and then extruded. The lipid concentration was determined by phosphorous analysis.
2.3. Preparation of Span 80 vesicle.
Span 80 vesicle was prepared by the two-step emulsification method (Kato et
a1.,2006).6 ml of n-hexane solution containing Span 80 and cholesterol was added to
0.6 ml of inner-phase liquid (155mM (NH4)2SO4 or PBS), followed by the first
emulsification for 6 min at 17,500 rpm using a micro-homogenizer NS-310E 2
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(Microtec Co., Ltd., Funabashi, Japan). The solvent obtained from the water-in-oil
emulsion w'as evaporated in a rotary evaporator aA-9 "C under reduced pressure,
yielding a water-lipid emulsion to which 6 ml of outer-phase liquid (PBS) containing 96
mg of TWeen 80 (and 85.2 mg DSPE-PEGzooo NOF Corporation)) was added, followed
by mixing with the homogenizer for 2 min at 3500 rpm to obtain the heterogeneous
Span 80 vesicle suspension. The heterogeneous vesicle suspension was stirred with a
magnetic stirrer for 3 hours at room temperature, followed by storage overnight at 4 "C.
The vesicle was then purified by ultracentrifugation (50,000 rpm at 4 oC for 120 min) in
a Himac centrifuge CR15B (Hitachi Koki Co., Ltd., Tokyo, Japan). The purified Span
80 suspension was passed through 100-nm nucleopore track-etch polycarbonate
membranes and purified twice by ultracentrifugation (When Span 80 vesicle were
prepared by (NH+)zSO+, Outer liquid phase was exchanged from (NHa)2SO+ to PBS).
2.4. Remote loading method.
Doxorubicin hydrochloride (DOX) was loaded into POPC liposome and Span
80 vesicle by a remote loading method (Haran et al., t993, Madden et al., 1990). In
short, surfactant vesicle suspension (50 mM) prepared by (NH+)zSO+ was then mixed
with a DOX saline solution (1 mM). To accelerate a loading of DOX, the sample was
then heated to 60 oC for each time. Afterwards, the unloaded material was removed by
using a gel permeation chromatography (SepharoseTM4B).
2.5. Cells and cell culture.
Murine osteosarcoma cell line (LM8 cell), murine rectal cancer cell line
(Colon26 cell), human hepatocellular carcinoma cell line (HepG2 cell) were obtained
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from RIKEN (RIKEN BRC Cell Bank, Ibaraki, Japan). These cells were grown in
Eagle's minimal essential medium (E-MEM) (Wako Pure Chemical Industries; Osdka,
Japan) supplemented with l0o/o fetal bovine serum (FBS) (Thermo Fisher Scientific;
Waltham, MA, USA) in the incubator (a humidified atmosphere consisting of 5 Yo COz
at37'C). Human osteosarcoma Takase (OST) cells were offered by Dr. Katsuro Tomita
(Department of Orthopaedic Surgery KanazawaUniversity School of Medicine, Japan).
OST cells were cultured in Dulbecco's Modified Eagle Medium (D-MEM) (Wako Pure
Chemical Industries, Osaka, Japan) supplemented with l0 % of fetal bovine serum
(FBS) at37 oC in a humidified atmosphere consisting of 5 Yo COz.
2.6. Evaluation of the cellular uptake of doxorubicin hydrochloride (DOX).
Colon26 Cells were seeded at2 x 105 cells/ml in a cell culture dish in complete
medium, E-MEM with 10% FBS for Colon26 cells. Colon26 cells were then incubated
for 24 hours in a humidified atmosphere of 5 o/o COz and at a temperature of 37 oC.
Then, test samples (PBS, DOX, DOX encapsulated liposome, and DOX encapsulated
Span 80 vesicle) were added to the cells and were further incubated for another t hour
under 5 % COz atmosphere and 37 oC. After incubation, cells were removed by
EDTA-Trypsin and washed by PBS twice. Co1on26 cells were analyzed by
flowcytometry @ife Technologies, Gaithersburg, MD, USA). Fluorescence intensity
excited at 488 nm was monitored with BP flter (575124 nm).
2.7.PITT assay.
MTT assay was perfo..1led by using CellTiter 96① Non―Radioactive Cell
Proliferation Assay(PrOmega;Fitchburg,WI,USA).The Cells(LM8 cells,Colon26
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cells, and HepG2 cells) were seeded on the 96 well cell culture plate (100 pl,2.0x10s
ceils/ml;. The cells were'cultured for 24 hours ih E-MEM supplemented with 10% FBS
in the incubator. The culture medium was exchanged by the new medium (100 pl)
containing Span 80 vesicle or DOX- loaded vesicles. The cells were incubated for 24
hours (37 oC,5% COz). The culture medium was exchanged by new medium (100 pl)
once more. The 15 pl of dye solution was added into the new medium. After incubation
for 4 hours in the incubator, the 100p1 of solubilization solution/stop Mix was added
into the new medium. After incubation for I hour at room temperature, the absorbance
of each well was measured by microplate spectrophotometer, xMarkrM (BIO-RAD;
Hercules, CA, U.S.A.). The ratio of cell viability was calculated from the following
equation;
R面o ofcell viabilけ
(3-1)
Asto(^) and A$s$1: Absorbance at 570nm and at 630nm, when the cells were added into
vesicle suspension
Asto(o) and A$sey: Absorbance at 570nm and at 630nm, without Span 80 vesicle
The 50% inhibitory concentration was estimated from the dependence of the cell
viability on the vesicle concentration.
2.8. Observation of blebbing formulation.
The cells (LMS cells, Colon26 cells, and HepG2 cells) were seeded on the 96
well cell culture plate (100 pl, 2.0x105 cells/ml), and were cultured for 24 hours in the
E-MEM supplemented with 10% FBS in the incubator. The culture medium was
exchanged by a new medium (90 pD. 10 pl of Span 80 vesicle (final concentration: 1.25
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mM) was added to the cell. The cells were observed at room temperature by
fluorescenbe microscopy, IX5 1 (Olympus; Tokyo, Japan).
2.9.Detection ofthe alteration of plasma lnembrane properties.
The alteration of plasma lnembrane properties was detected by double stalning
method with the combinatiOn Of Amexin 5 and 7-ADD,and with the combination of
F2NlS and SYTOX①.Both cxperllnents were perfo..1.ed by using PE Amexin V
Apoptosis Detection Kit I(BeCtOn Dickinson Biosciences;Framdin Lakes,NJ,U.S.A.)
and Violet Ratiometric Membrane As_etry Probe/Dead Cell Apoptosis Kit(Life
Technologies,Inc.;Carlsbad,CA,UoS.A。),reSpect市ely.
LM8 cells were seedcd on the 6 well cell culture plate(2.O ml,2.0×105
cells/ml).LNI18 cells werc cultured for 24 hours in E―MEM supplemented with 10%
FBS in the incubato■The culturc mcdium was exchangcd by a new medillm(2.O ml)
containing PBS,staurospo五ne(0.43 mM),or Span 80 vesicle(1。25 mM)。A■er the
incubatiOn for 3 hours,the cells were treated with EDTA―Trypsin and washed by PBS
twice.
When double staining of F2NlS and SYTOX① was achieved,LM8 cells were
re―suspendcd in 500 1tl PBS,l μl F2N12  and SYTOX①AADvancedTM dead cell stain
solution, and where incubated for 5 1nin. LM8 cell suspension diluted by PBS was
analyzed by Attune① Acoustic Focusing Cytomete■
When double staining of Amexin 5 and 7¨AE)D was perfol.1.ed, LNI18 cells
were re―suspended in 500 1tl of l×binding bu]た■ 100 μl of the cell suspension was
added 5 μl Amexin 5¨PE and 7-ADD,followed by incubation for 15■lin.LM8 cell
suspension was added more 4001tl of l×binding buffct and was analyzed by Attune①
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Acoustic Focusing Cytometer.
2.10. Annexin 5 -PE staining (observation by fluorescence microscopy).
LMS cells were seeded on the 96 well cell culture plate (100 pl,2.0x105
cells/ml), and were cultured for 24 hours in the E-MEM supplemented with 10% FBS in
the incubator. The cell culture medium was exchanged by the new medium (100 pl)
containing PBS, staurosporine (0.43 mM) or Span 80 vesicle (1.25 mM). After the
incubation for 3 hours, the culture medium was removed. 30 pl binding buffer and 5pl
Annexin 5 -PE were added for each well. After incubation for 30 min at room
temperature, these cells were observed by fluorescsnce microscopy, IX5l, after
exchanging the binding buffer for PBS.
2。11.Observation of F‐actin
F―actin was obseⅣcd by using Phalloidin,Alexa FluolP488 Cottugatc(Life
Technologies,Llc。;Carlsbad,CA,USA).The Cells were seedcd on the coverslip in thc 6
well cell culture plate(2.O ml,2.0×105 cellS/ )。The cells were cultured for 24 hours in
E―MEM supplelnented with 10% FBS in the incubato■ The culture medi m was
exchanged by a new medium(2.O ml)COntaining PBS,or Span 80 vesicle(1.25 mNl).
After the incubation for 3 hollrs,the cells were washed by PBS twiceo The cells were
flxed by in 4.0%fo..1laldehyde solution in PBS for 10 1nin at room temperature.The
flxed cells were washed by PBS twice. The cells were incubated with O.1%
Triton°X-100 in PBS for 3 min.The cells were stained with the fluorescent pha1lotoxin
(5μl fluorescent phalloto対n was diluted by 200μl PBS)whiCh Was added l%bo宙ne
serllm albllllnin in order to reducё nonspeciflc background for 20 ■lin at room
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temperature. The stained cells were observed by the confocal fluorescence microscopy,
BX50 (Olympus; Tokyo, Japan).
2.l2.Modification of ESAon the vesicle membrane
ESA was extracted from the red alga Eucheuma serra, by means of ethanol
precipitation, followed by purification with fast protein liquid chromatography (FPLC),
using a 10 mM sodium phosphate buffer (pH : 7.4) (Kawakubo et al., 1997). ESA was
anchored to 1,2-dioleoyl-sn-glycero3-phosphoethanolamine-N-(succinyl) (SuPE). 100
pL of a SuPE solution (I.25 mglml. in chloroform) were added to a test tube. A thin film
of SuPE formed after evaporation of chloroform under a stream of nitrogen gas.
Afterwards, 2.5mL of an ESA solution (0.675 mglmL) were added to the film to react
with SuPE in 0.15M sodium carbonate buffer (pH9.0) at room temperature. The reaction
mixture was incubated for 2 hours with vortexing for a few seconds every 30min,
followed by letting the suspension stand at 4 oC overnight. Residual SUPE in the buffer
solution was removed by gel filtration with a PD-10 column packed with Sephadex
G-25 (GE Healthcare; Buckinghamshire, England). ESA-SuPE conjugation was added
at second emulsification (Section 2.3).
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3. Results and Discussion
3.L. Design Scheme of Drug Carrier for Effective Drug Delivery
The importance of membrane property to control the oomembrane-membrane"
interaction was shown in the previous section (Chapter 2)by employing the lipid- and
detergent-vesicles as target materials. The relationship between the membrane
properties of the surfactant vesicle and their membrane-membrane interaction can
contribute to the rational design of drug carrier to achievement of the effective drug
delivery. The design scheme of drug carrier to control the interaction of the vesicle, as a
drug carrier, with the biological cells is herewith shown in the Fig. 3-1, based on the
findings obtained in chapter L and chapter 2.
It is expected that headgroup mobility of surfactant vesicle (Membrane
property: "Flexibleon) is an important key factor to affect the uptake pathway of the
drug carrier into the cells. The headgroup mobility of phosphatidylcholine liposome was
inhibited by the electrostatic interaction of headgroup region, resulting in the reduction
of the binding of phosphatidylcholine liposome to the plasma membrane. This weak
interaction between phosphatidylcholine liposome and a plasma membrane is expected
to induce the uptake of drug carier by the cell-dependent uptake mechanism,
endocytosis. In contrast, intensively-high head mobility of the headgroup of Span 80
vesicle improves the binding of Span 80 vesicle to the plasma membrane. The dynamics
of Span 80 molecule on the Span 80 vesicle membrane induces the membrane fusion
between Span 80 vesicle and the plasma membrane after the interaction with the plasma
membrane.
After the fusion with the plasma membrane, Span 80 molecule diffrrses on the
plasma membrane from their binding region to other region. Span 80 molecule
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Fig. 3-1 Design scheme for effective drug carriers to control the interaction between
detergent-based membrane and phospholipid-based membrane.
immediately diffuse on the plasma membrane, considering the high membrane fluidity
(Membrane propertyz "Ffuif') of Span 80 vesicle. The immediate diffusion of Span
80 molecule on the plasma membrane alters the membrane propefties of the plasma
membrane, resulting in the induction of cell death.
The membrane polarity (Membrane property: "Wet") is also important to
encapsulate the drug efficiency. In the case of remote loading method, DOX is
encapsulated across the membrane of the surfactant vesicle membrane. The existence of
water molecule on/in the surfactant vesicle membrane prevents the insertion of the DOX.
Therefore, "wet" membrane is not appropriate for the encapsulation of DOX.
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The targeting of intracellular organelle has recently become an important issue,
with the iecent progress in the deeper understanding'of the case of cellulai diseases.
Considering the "Flexible", ooFluit', artd ooWet" nafures of the surfactant vesicles, the
vesicle-in-vesicle was designed based on the scheme to minimized the interaction
between the Span 80 vesicle and phospholipid vesicle with keeping their higher
interaction ability with plasma membrane.
It has been reported that there is a difference of the plasma membrane
component between normal cells and cancer cells. In order to increase the selectivity of
drug carrier against the cancer cells, the modification of antibody (i.e. anti-EGFR
antibody or folate) is one of the effective strategies for the high efficiency drug delivery.
Moreover, metabolic mechanism containing glycosylation is different between cancer
cells and normal cells, resulting in the different sugar chain structure on the plasma
membrane between cancer cells and normal cells. It has been reported that sugar chain
binding protein, lectin, is also effective for the cancer-targeting ligand on the surface
vesicle membrane, although the modification condition for the lectin has not been
optimized yet. The method to design an appropriate membrane surface of the surfactant
vesicle was also shown based on the design scheme.
3.2. Direct Drug Delivery Based on 66Flexible" Nature of Span 80 Vesicle.
The importance of headgroup mobility in the interaction of the vesicles with
the plasma membrane was shown as the first step of the scheme of drug carrier design
(Fig. 3-1). The intense mobility of Span 80 molecule on its vesicle surface can realize
an effective drug delivery to the cancer cells, and can also induce the fusion with plasma
membrane. ln this section, Span 80 vesicle was added into the cholesterol (23.1moI%)
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to reduce the drug permeability from Span 80 vesicle membrane with the reduction of
membrane fluidity (Shimanouchi et al., 2009). DOX was firSt entrapped in the Spbn
80/cholesterol vesicle by a remote loading method. The DOX-entrapped Span
80/cholesterol vesicle was incubated with Colon26 cells, to investigate the role of Span
8O/cholesterol vesicle. Figure 3-2 shows the amount of DOX uptaken by Colon26 cells,
determined from the mass balance of DOX fluorescence. Almost all the Span
80/cholesterol vesicles entrapping DOX was uptaken by Colon26 cells in contrast to the
case of POPC liposome. It seems that the intense mobility of headgroup of Span 80
molecule on the vesicle surface could induce their easy insertion into the plasma
r00
80
60
40
20
0
to3 to4 to5
Fluorescence Intensity (-)
ro3 104 ro5
Fluorescence Intensity (-)
(a) 
- 
PBS(control)(b)- oox
(c) 
- 
DOX encapsulated liposome
(d) 
- 
DoX encapsulated Span 80 vesicle
Fig. 3-2 Flowcytogram of Colon26 cells at (a) 37 oC and (b) 4 'C. Colon26 cells were
treated with (a) PBS (control) ( 
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), (b) DOX ( 
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) (c) DOX encapsulated
liposome ( 
- 
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(B)4"C
membrane that is similar to liposome membrane (Chapter 2) as compared with the case
of POPC liposome. These results suggest that ihe dynamics of membrane surface is
important to control the interaction with the plasma membrane rather than inner
membrane properties, considering the value measured by DPH (Figs. l"-5 and 1-6). The
intense of headgroup mobility of the Span 80 vesicle (f,r > 200 MHz) is strong enough
to interaction with the plasma membrane.
There are some possibilities to explain the cellular uptake mechanism of the
drug delivery using surfactant vesicles. After interaction with the plasma membrane,
POPC liposome is commonly known to be uptaken by endocytosis, while the uptake
pathway of Span 80 vesicle is considered to be different from POPC liposome in the
case of Co1on26 cells. In order to clarify the internalization mechanism of DOX
encapsulated in POPC liposome and in Span 80 vesicle, their binding to Colon26 cells
was investigated under 4'C-incubation that could inhibit the endocytosis pathway (Fig.
3-2 (B)). The peak of DOX encapsulated POPC liposome (peak c) was shifted to the
control (peak a) as compared with that at 37 'C. The observed shift of DOX
encapsulated into the POPC liposome probably resulted from the uptake of the DOX
under 4 oC -incubation, as previously reported in the another literature (Elbayoumi and
Torchilin, 2007).It is therefore considered that the DOX-encapsulated POPC liposome
used here was internalized via an endocytosis pathway. In contrast, the peak of DOX
encapsulated Span 80 vesicle (peak d) was not obviously shifted to the peak at 4 oC. The
DOX encapsulated Span 80 vesicle was thus found to be up-taken by the different
pathway from the endocytosis observed in the DOX encapsulated POPC liposome.
Moreover, the uptake mechanism of Span 80 vesicle by Co1on26 cells was
confirmed by the confocal laser scanning microscope. Figure 3-3 shows the image of
?
?
?
?
(a)POPC Liposome (b) Span 80 vesicle
Fig. 3-3 Confocal laser microscopic images of DOX encapsulated (a) POPC liposome
and (b) Span 80 vesicle. Green fluorescence: NBD-PE; red fluorescence: DOX.
Colon26 cells treated with DOX encapsulated in (a) POPC liposome, or in (b) Span 80
vesicle. The dotted green (NBD-PE) and red (DOX) fluorescence in cytosol of Colon26
cells could be observed at the same region in the case of POPC liposome. This
observation is a definite evidence that the DOX encapsulated into the POPC liposome
was internalized by the endocytosis pathway. On the other hand, green fluorescence
derived from NBD-PE was observed at the plasma membranes, as shown in Fig. 3-3.
This observation implies the lipid mixing between the Span 80 vesicle and plasma
membrane. Red fluorescence derived from DOX was also observed at the inside of
Colon26 cell cytoplasm, implying the direct delivery of DOX into the cytoplasm of
Colon26 cells. From this double-staining experiment, it is considered that the Span 80
vesicle delivered the DOX into the cytoplasm of cells via membrane fusion of Span 80
vesicle with the plasma membrane. These interaction mechanisms are controlled by the
flexibility of the surface, the intense of headgroup mobility of the Span 80 vesicle (f,i >
200MHz) is enough to fuse with the plasma membrane (Fig. 3-a).
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Fig. 3-4 Scheme of the mechanism of interaction between surfactant vesicle and
plasma membrane. (a) The surfactant vesicle with low-intense headgroup
f"i < 60 MHz) on the membrane was uptaken by endocytosis pathway. (b)
The surfactant vesicle with high-intense headgroup (f"i> 200 MHz) on the
membrane was uptaken by membrane fusion.
3.3. Partial Transformation of Plasma Membrane to induce Cellular Response
through the Fusion of Span 80 vesicle -Induction of "Pseudo-Apoptosis"-
After the fusion with the plasma membrane, Span 80 vesicle/molecule diffuses
on the plasma membrane, considering the lipid mixing. The results of chapter 2 suggest
that the diffrrsed Span 80 vesicle/molecule could alter the membrane properties of the
plasma membrane. According to the scheme (Fig. 3-1), the "fluidity" (llP value) is the
key factor for the cytotoxicity. The plasma membrane was highly regulated to operate
the cellular mechanism, such as signaling (Allen et al., 2007, Ostrom and lnsel, 2004),
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or substance transport (Eckford and Sharom, 2008, Razani et al., 2002), possibly
togeth'er with the variation of their membrane proilerties. The alteration"of membrane
properties is thus one of the important issues for the control of membrane function. In
this section, the effect of Span 80 vesicle for the cells was investigated after its insertion
into the plasma membrane.
(1) General Cellular Response after Fusion of Span 80 vesicle
The cytotoxicity of Span 80 vesicle/molecule was evaluated after its fusion
with the plasma membrane. It has been shownthat, after its interaction with the plasma
membrane, Span 80 molecule could difhrse on the plasma membrane as described
above (Section 3.2.). The above case study implies that the plasma membrane of
biological cell can be partially transformed through the membrane fusion of "foreign"
vesicle that differs from lipid vesicle in relation to their nature. It has been reported that
the membrane-related phenomena can be induced by modifying the membrane
properties by adding some reagents or by change the environmental condition. It is
considered that the cellular response can also be induced through the fusion of Span 80
vesicle with fluid, flexible, and wet surface. Various cellular responses were observed
after the fusion of Span 80 vesicle. From the microscopic observation, blebbing was
observed after the cells were treated with Span 80 vesicle. After incubation, Span 80
vesicle finally induces the cell death for these cells. In order to investigate the effect of
cell line, LMS cells, Colon26 cells, and HepG2 cells were treated with Span 80 vesicle
and were incubated for 3 hours, resulting in the observation of blebbing by microscopic
observation (Fig. 3-5(a)). The sensitivity of the Span 80 vesicle is dependent on the cell
line. Among the cells tested here, LM8 cells induced the blebbing more frequently as
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Fig. 3-5 The observation of cellular blebbing, and evaluation of cytotoxicity of Span 80
vesicle for cells. (a) The microscopic image of LM8 cells, Colon26 cells, and
HepG2 cells. These cells were treated with Span 80 vesicle, resulting in
blebbing after 3 hours. (b) The frequently of blebbing was evaluated for these
cells. LM8 cells formed bleb most frequently than other cells. (c) The scheme of
the cells with bleb on the plasma membrane by treated with Span 80 vesicle.
compared with Colon26 cells or HepG2 cells (Fig. 3-5(b)). 92.2 % of LM8 cells in
population were found to induce the blebbing, while 27.6 % and 19.3 Yo of Colon26
cells and HepG2 cells were population with bleb. The LM8 cells were also sensitive for
the cytotoxicity of the Span 80 vesicle as compared with other cell lines through the
MTT assay (Fig. 3-6). Figure 3-6(b) shows the 50% inhibitory concentration (ICso) of
Span 80 vesicle which was determined by Fig. 3-6(a). The ICso value of the Colon26
cells was 1.82 times more, and that of HepG2 was 3.99 times more than that of LM8
cells. In the following experiment, the LM8 cell line was selected as a target because of
its higher sensitivity.
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Fig. 3-6 Span 80 vesicle finally induced the cell death. (d) Cell viability of these cells
treated with Span 80 vesicle was measured by MTT assay, and (e) the 50yo
inhibitory concentration (IC5e) was calculated.
(2) Bleb formulation by treatment with Span 80 vesicle is related with actin
filament.
The mechanism of blebbing induced by Span 80 vesicle was further
investigated, focusing on the "actirf' which is the scaffold protein on the plasma
membrane. Actin is well-known as one of the cytoskeleton protein, which can regulate
the cellular adhesion (Parsons et a1., 2010), or the cell movement (Salbreux et al., 2012).
The actin can also regulate the cellular shape (Salbreux et a1., 2012). It has been
reported that there is a relationship between bleb and actin filament (Charras and Paluch,
2008). TWo kinds of models on the bleb formulation have previously been proposed
(Fig. 3-7): Bleb initiation can result from a local detachment of the cortex from the
membrane or from a local rupture of the cortex (Charras and Paluch, 2008), while it is
not clear about the blebbing mechanism.
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Fig.3-7 Mechanism of bleb formation. (a) Local detachment of the cortex from the membrane.
(b) Local rupture of the coftex.
Blebs of LM8 cells induced by Span 80 vesicle is also related with actin. LMS
cells treated with Span 80 vesicle were fixed by formalin, and were stained with
Phalloidin, Alexa Fluor@488 Conjugate. Figure 3-8 shows the confocal macroscopic
image of LMS cells. When LMS cells were treated with PBS as control, actin filament
was observed in the side of basolateral membrane. When LM8 cells with bleb by treated
with Span 80 vesicle were observed, actin filament was found to be extended around the
inside of bleb of LM8 cells. This result suggests that the blebbing initiated by the
addition of Span 80 vesicle was not formed as non-biological (such as, physical)
response, but as biological response (cellular response).
Blebbing formation is related with the cell death mechanism. Apoptosis and
necrosis are well known as main categories of the type of cell death (Leist and Nicotera,
1997). The difference of cellular response between apoptosis and necrosis has been
reported, together with many features, such as the alteration of the plasma membrane,
nucleus structure, expression of protease, and so on (Table 3-1) (Leist and Nicotera,
1997). Apoptotic process, well-known as the program cell death, is also one of the
Actin firmament
94
cellular responses correlated well with the plasma membrane, apoptotic bleb (Kepp et
aI., 201I, Onenius et al., 20ll). On the bther hand, the mechairism of the necrosis hhs
not been clarified, especially, in relation to the response of plasma membrane, in
contrast to apoptosis. The lysis of the plasma membrane was only recognized as the
feature of necrosis (Kepp et a1., 2011, Melino et a1., 2005). Considering the difference of
membrane feature between apoptosis (apoptotic bleb) and necrosis (Lysis), LMS cells
were shown to induce the apoptotic cell death by their treatment with Span 80 vesicle.
On the other hand, it has recently been reported that the blebbing is observed when the
cells induce necrosis on a particular occasion. Blebs have thus been regarded as
unconventional necrotic feature. In another previous report, necrotic blebs induced by
H2O2 appear much later as compared with apoptotic blebs (Barros et a1.,2003). The
mechanism of blebbing is different between apoptosis and necrosis, and necrotic blebs
are not regulated by ROCK-I, MLCK, and p38MAPK differently from apoptotic bleb
(Barros et a1.,2003). However, almost all necrosis was observed as only lysis of plasma
membrane. It is therefore considered that Span 80 vesicle should induce apoptosis for
the cells.
(3) Pseudo-Apoptotic Responsel the Induction of Blebbing and Cell Death for
Cancer Cells by Treated with Span 80 Vesicle.
Considering the alteration of the membrane properties of liposome by lipid
mixing with Span 80 vesicle (Chapter 2), it is suggested that the plasma membrane
fluidity is increased by its interaction with Span 80 vesicle. It is considered that the high
membrane fluidity of Span 80 vesicle is advantageous to injure the plasma membrane.
The increase of the membrane fluidity of plasma membrane is expected to be induced
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by the disruption of the regulation of membrane properties, such as asymmetry of lipid
component. The blebbing and cell death induced by Span 80 vesicle were further
investigated, focusing on the mechanism whether apoptosis or necrosis. The observation
of phosphatidylserine exposure was employed as the method of the detection of
apoptosis in this study (Kepp et a1.,2011). The phosphatidylserine was usually located
at inner leaf of the plasma membrane (Leventis and Grinstein, 2010). However, the
phosphatidylserine is exposed when cells induce apoptosis (Stowell et al., 2009). The
phosphatidylserine exposure can be detected by fluorescence probe (F2N12S) (Shynkar
et a1.,2001), or phosphatidylserine binding protein (Annexin) (Gerke and Moss, 2002)
(Fig.3-e).
The double staining of F2N125 and SYTOX@ was performed in order to clarify
the alteration of the plasma membrane when LMS cells were treated with Span 80
vesicle. F2N12S and SYTOX@ were employed as the marker of the alteration of the
Ex:488 nmEm:575 nmEm:530 nm
Annexin 5 -PE
eee ee
Phosphatidylse rine
Fig. 3-9 Schematic illustration of phosphatidylserine exposure. The fluorescence of
F2I2S is altered from 585 nm to 530 nm by exciting at 405 nm by
phosphatidylserine exposure. Annexin 5-PE binds to the phosphatidylserine
on the outer leaflet when cell induce the phosphatidylserine exposure. The
fluorescence at 575 nm is observed by exciting to the annexin-5 PE at 488
nm.
○○
Enl:585 nm
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plasma membrane properties and dead cells, respectively. F2N12S@, which is known as
environmentally-sensitive fluorescence probe and can make a response to the changes in
membrane asymmetry increased the membrane fluidity and the negative charge on the
surface together with the progress of apoptosis (Shynkar et a1., 2007). X-Axis and
Y-axis shown in Fig. 3-10(a) indicate [F2N12S ratio 585 nm/530 nm] and [SYTOX@
fluorescence intensity], respectively. R4, R3, and Rl regions show living cells,
apoptotic cells, and dead cells, respectively. The 46.3% of the cellular population treated
with staurosporine and the 76.0% of the cellular population treated with Span 80 vesicle
were observed at R3 region. This result suggests that the membrane properties of cells
were transformed to those of apoptotic cell by the treatment with Span 80 vesicle. In
order to evaluate the plasma membrane property, the double staining of Annexin 5-PE
and 7-ADD was also performed. Annexin 5-PE and 7-ADD were employed as the
indicators of the exposure of PS, and dead cells, respectively. The 15.lo/o of the cellular
population treated with Span 80 vesicle were shown at R4 (Annexin 5-PE +i7-ADD -)
by flow cytometry analysis (Fig. 3-10(b)). The fluorescence of the Annexin 5-PE was
also observed by microscopy, when LM8 cells were treated with Span 80 vesicle (Fig.
3-11). These results suggest that the exposure of PS by its treatment with Span 80
vesicle, i.e. LM8 cells induced apoptotic like cell death by its treatment with Span 80
vesicle.
3.4. Vesicle Delivery Considering the Targeting to the Organelle Inside Cells
In the above section, the pharmacokinetics of drugs encapsulated into
surfactant vesicles was described. In this section, an alternative approach to achieve the
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Fig. 3-10 Alteration of the plasma membrane of LM8 cells by treated with Span 80
vesicle. (a) Nature of LM8 cell membrane was altered like as early in
apoptosis by treated with Span 80 vesicle. Percentage of LM8 cells in R1
and R3 was increased in both case of treated with staurosporine and Span
80 vesicle, compared with PBS treatment. (b) Exposure of PS was also
observed by double staining of Annexin5-PE and 7-ADD. Exposure of PS
was observed accompany with increasing of uptake of 7-ADD by treated
with Span 80 vesicle.
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Staurosporine
Span 80 vesicle
Fig. 3-11 Image of the fluorescence microscopy. Exposure of PS was also observed when
LM8 cells adhered on cell culture plate. (Red: Annexin5-PE, Blue: Hoechst
33342 (nuclear))
controlled release of drug was proposed based on the control of different membranes
such as Span 80 vesicle, DPPC liposome, and plasma membrane by selecting the
encapsulation of liposome-based drugs by the liposomes as case study. The most
promising strategy is the vesicle-in-vesicle system, where vesicles prepared from one
type of amphiphile were encapsulated in another vesicle prepared from a different
amphiphile (McPhail et al., 2000). It has been demonstrated that the vesicle-in-vesicle
could achieve the controlled release because the second inner vesicle, entrapped inside
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the first outer vesicle, gave a certain permeation resistance to the model drug loaded
into the encapsulated vesicle (McPhail et al., 2000). Vesicle-in-vesicle system has
another beneficial point that the second vesicle could reduce the side-effect of
liposome-based drugs, due to the compartment effect of lipid membrane of the second
vesicle. Meanwhile, the preparation using a hydration method has a difficulty in
controlling the lipid composition of vesicles during the formation of vesicle-in-vesicle
system (McPhail et al., 2000). The major objective in this section is to combine Span 80
vesicles with conventional vesicle-in-vesicle system for a novel drug delivery system
(Fig. 3-12). It seems that the first outer vesicle can release the second inner vesicle to
the cytoplasm of biological cells with the membrane fusion between the first outer
vesicle and plasma membrane, resulting in the delivery for the organelle by using the
second inner vesicle. In order to pursue the above purpose, the interaction between Span
n 80 vesicles
Liposome
Fig. 3-12 Scheme of the strategy of organelle targeting by using vesicle-in-vesicle
?
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system.
80 vesicle and DPPC liposome should be minimized to avoid the fusion of themselves
and, the interaction between the Span 80 vesicle and plasma membrane should be
maximized from efficient delivery. The characters for two kinds of vesicles were
optimized based on the scheme (Fig. 3-1).
ln short, the method to prepare the vesicle-in-vesicle system was described
below. The vesicle-in-vesicle was prepared by the two-step emulsification method, as
described above. ln this case, the liposome suspension was added into the Span 80
solution (n-hexane) as a inner phase at first emulsification (Fig. 3-13). As a result, the
Span 80 vesicle entrapping the phospholipid vesicle can be obtained as a final product.
For the drug delivery into the intracellular organelle, the cytotoxicity of Span
80 vesicle for the cells needs to be prevented. Considering the sensitivity of the
cytotoxicity of Span 80 vesicle for the cell line, HepG2 cells and Span 80 vesicle were
employed as target. According the scheme (Fig. 3-1), Span 80 vesicle and DPPC
liposome were used as the first outer vesicle and the second inner vesicle, respectively.
An interaction of the vesicle-in-vesicle system with HepG2 cell membrane was then
investigated. First, DPPC liposome, stained by rhodamine-PE (Rh-PE), was used to
Lst-emu lsif ication
Addition of liposome
suspension/^: l-l \>cHll\a)"tl
Lipoime l, ,suspensron I r
iware' phrsO | /' .
spanSo \-2
(Organic phase)
?
???
2nd-em u lsification
Water addition
,A\ I
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organic phase
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Fig. 3-13 Preparation method of the vesicle-in-vesicle system.
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Fig. 3-14 Fluorescence microscopic images of HepG2 cells treated by
Rhodamine-stained (a) vesicle-in-vesicle system and (b) DPPC
liposome.
prepare the Rh-stained vesicle-in-vesicle system (Rh-LVs). This vesicle-in-vesicle
system was added into HepG2 cells. Figure 3-14 shows the confocal laser microscopic
images. In the case of vesicle-in-vesicle system, red fluorescence originated from
rhodamine was observed inside the HepG2 cells. [n contrast, the addition of DPPC
liposomes stained by Rh-PE resulted in the dotted red fluorescence inside the cells,
suggesting the up{ake of liposome via an endocytosis. These results suggest that the
second inner vesicle (DPPC liposome) was released from the first outer vesicle (Span
80 vesicle), resulting in the expected drug delivery to the organelle by the drug
encapsulation into the second inner vesicle (DPPC liposome).
It is necessary to consider the interaction between second inner vesicle and
organelle membrane. Organelle membrane is also composed by the various kinds of
phospholipids, the component of organelle membrane is diflerent from each organelle,
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such as golgi body, or mitochondria (van Meer et a1.,2008). The design of not only the
first outer vesicl'e but also second inrier vesicle is therefore needed. In the case'of
mitochondria targeting drug delivery, there is a previous report on vesicle-in-vesicle
system (MITO-Porter) based on the membrane properties (Yamada et al., 2008).
Mitochondrial membrane contains more anionic phospholipid,
phosphatidylethanolamine (van Meer et a1., 2008). The second inner vesicle of
MITO-Porter contains cationic lipids, where this vesicle easily interacts with anionic
mitochondrial membrane. Therefore, the design of the surface charge of the surfactant
vesicles is important for the case of organelle targeting drug delivery.
3.5. Design of Antibody 
- 
Displayed vesicle 
- 
the Modification of Span 80 Vesicle
Membrane by Novel Lectin Eucheuma serra Agglutinin -.
The modification of vesicle membrane with proteins, peptides, and small
molecules on the liposome membrane enhances the selectivity for the cancer cells.
However, a general strategy on the modification of the surfactant vesicle with dynamic
membrane has not been reported yet. The membrane properties could be presented by
the optimal modification of membrane by protein according to the design scheme (Fig.
3-1). The amount of protein modifying the membrane surface of surfactant vesicle was
regulated in order not to affect the membrane properties. In this section, the activity of
protein was evaluated on the Span 80 vesicle membrane, by using Eucheuma serra
Agglutinin (ESA) as a model protein. ESA is the lectin derived from marine red alga
(Kawakubo et al., 1997) and, specifically, binds to the high mannose sugar chain
structure (Hori et aI.,2007).It has been reported that the ESA can specifically bind to
the sugar chain on the membrane surface of cancer cells, without binding to the normal
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fibroblast cells (Sugahara et al., 2001). After the Span 80 vesicle was modified with the
ESA on the surface of the vesicle membrane, the ESA-modified Span 80 vesicle was
added to the OST cells.
Figure 3-15 shows the affinity of ESA-modified Span 80 vesicle to the OST
cells. The fluorescence intensity of OST cells was more increased by the treatment with
ESA modifying Span 80 vesicle as compared with that in the case of unmodified Span
80 vesicle. It is suggested that ESA modif,red on the Span 80 vesicle bind to the high
mannose sugar chain of the OST cell membrane, resulting in the selective binging to the
cancer calls by using Span 80 vesicle (Fig. 3-16). Moreover, ESA modifying pegylated
Span 80 vesicle was also evaluated in relation to its affinity for OST cells. Pegylation of
unmodified Span 80 vesicle
ESA-modified Span 80 vesicle
ESA-mod ified pegylated
Span 80 vesicle
Fig. 3-15 Flow cytometric analysis of the interaction between OST cells and
different types of Span 80 vesicles containing entrapped FITC:
unmodified Span 80 vesicle ( 
- 
), Span 80 vesicles with immobilized
ESA ( 
- 
), and pegylated Span 80 vesicle with immobilized ESA ( 
- 
).
Before analysis, the OST cells were incubated with the vesicles during
15 min at 37 oC in a humidified atmosphere of 5 o/o CO2. PBS was
added to OST cells as control (red fill).
『?
．?〕??????
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Eu ch e u ma se rro Aggl utinin
(EsA)
Fig. 3-16 Eucheuma serra Agglutinin (ESA) specifically bind to the high
mannose type sugar chain on the cell surface. It is expected to the
selective bindine to the cancer cells.
surfactant vesicle like Doxil@ is expected to be escaped from the natural immunity by
the hydration layer as described above (General Introduction), while it is needed to
consider the inhibition of protein activity by hydration layer or steric hindrance. ESA
modifying pegylated Span 80 vesicle was found to bind to OST cells as same as ESA
modifying Span 80 vesicle. This result shows the capability of multi modification on the
Span 80 vesicle membrane.
On the other hand, a certain level of unmodified Span 80 vesicle also bound to
OST cells. This binding afhnity was only contributed to "membrane-membrane"
interaction. These results suggest that not only modified protein but also the membrane
properties of surfactant vesicle are important for the binding to the plasma membrane.
However, it is needed to consider the protein behavior on the surfactant vesicle
membrane in order to clarify the contribution of protein to the binding for cancer cells.
ESA is known to possess four active sites in the signal molecule. It is considered that
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Fig. 3-17 Scheme of the strategy of organelle targeting by using vesicle-in-vesicle
svstem.
the dynamic membrane of Span 80 vesicle could mask the active sites of ESA. When
the active site of ESA can be hidden in the Span 80 vesicle membrane, it is needed to
expose the active site of the antibody to the outside of the vesicle membrane. The hybrid
vesicle was proposed as an idea (Fig. 3-17). The hybrid vesicle was prepared by mixing
with Span 80 molecule and saturated lipid, resulting in the formation of the
heterogeneous (liquid crystalline - gel phase) vesicle. The part of membrane with gel
phase is expected to prevent the insertion of protein into the surfactant vesicle
membrane. It has been confirmed that the active sites of the antibody molecule can be
preserved in the hybrid vesicle modified with another kind of antibody (Concanavalin
A) (data not shown). The design of membrane of the surface vesicle should be effective
for the important of protein binding activity on the membrane.
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4. Summary
' The design of drug carrier based on the interaction mechanism is important to
develop the efficient drug delivery. For example, the liposome is with less-interacting
nature with the plasma membrane, resulting in the inefficient drug delivery to the cells.
ln order to increase the interaction with the plasma membrane, the dynamics of
membrane surface need to be improved. Considering the results of chapter 2, the
design scheme of drug carrier was established (Fig. 3-1). According to this scheme, the
headgroup mobility was shown to be an important key factor to improve the drug
delivery efficiency. The surfactant vesicle with low intense headgroup mobility is
uptaken by the endocytosis. Endocytosis pathway is disadvantageous for the drug
delivery resulting in the elimination of the delivered drug by the exocytosis. On the
other hand, the surfactant vesicle with high intense headgroup mobility can be uptaken
by the 'omembrane fusion", resulting in the direct and effective drug delivery.
After the fusion with plasma membrane, the surfactant molecules of vesicle
diffrrse on the plasma membrane, resulting in the alteration of the plasma membrane
properties. The plasma membrane properties were highly related to the cellular
regulation, which is important to control the membrane function such as membrane
traffic or cellular signaling. It is therefore considered that the alteration of the plasma
membrane properties can induce the damage to the cells. As expected, the cells induced
the cell death with the bleb formation after the treatment with Span 80 vesicle. The
membrane fluidity of Span 80 vesicle is higher as compared with the plasma membrane
as previously reported (Kaur and Sanyal, 2010). The cell death mechanism by the
disruption of the membrane composition was demonstrated by observation of
phosphatidylserine exposures. The phosphatidylserine is usually located at inner leaflet
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of the plasma membrane, while phosphatidylserine transported to the outer membrane
by induction of apoptotic cell death. Therefore, the treatment of Span 80 vesicle fbr the
plasma membrane induces the alteration of membrane properties similarly in the case of
apoptotic cell death.
Moreover, the scheme of drug carrier is useful for more complex drug delivery
such as organelle targeting drug delivery. The vesicle-in-vesicle system was herewith
proposed as a case study. DPPC liposome (second inner vesicle) was encapsulated into
the Span 80 vesicle (first outer vesicle). Span 80 vesicle fuses with the plasma
membrane, and releases DPPC liposome from the Span 80 vesicle. In this system, the
strong interaction with the plasma membrane is important to carry out an effective drug
delivery to the cells. The diffusion of Span 80 vesicle on the plasma membrane induces
the cell death as described above. In the case of the drug delivery targeting an organelle
by using the vesicle-in-vesicle systems, the cytotoxicity of Span 80 vesicle for the cells
can be reduced, resulting in the prevention of the induction of cell death.
The mernbrane properties are also altered by the modification of the protein,
ESA. ESA was modified on the membrane of Span 80 vesicle. It has been reported that
ESA is lectin specifically binding to the high mannose sugar chain structure. ESA can
specifically bind to the sugar chain on the cancer cell membrane. The binding affinity of
Span 80 vesicle for the cancer cells was increased by the modification of ESA on the
Span 80 vesicle membrane. Moreover, pegylation of ESA-modified Span 80 vesicle did
not affect the binding affinity for cancer cells, suggesting no effect for the ESA binding
activity by pegylation.
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General Conclusion
' A general strategy to control thei interaction between" different kinds of
membranes has not been established yet, because there is less information on the
physicochemical properties of "molecular assembly'' itself. In this thesis, the author
mainly focus on the establishment of the systematic design of the interaction between
the different membranes of surfactant vesicles (i.e. detergent vesicle and phospholipid
vesicle) based on the key properties of their membrane (as a'omolecular assembly''). As
the first step of this investigation, new kinds of membrane properties of the surfactant
vesicles have been characterized in addition to the conventional property (i.e.
"membrane fluidity''), where the "flexible", "fluit', and "wet" natures of the membrane
surface were shown to be important to understand the character of the membrane from
the systematic viewpoint (Chapter 1). Secondly, the oomembrane-membrane"
interaction was further studied through both calcein leakage and lipid mixing analyses,
mainly focusing on its relationship with the above-characterized membrane properties,
by employing the detergent vesicle (Span80 vesicle) and phospholipid vesicle
(phosphatidylcholine liposome) as target membrane to be mutually interacted (Chapter
2). Based on the above findings, a design scheme to control the membrane-membrane
interaction based on the membrane properties was finally proposed, together with its
extension for some kinds of applications, by employing (i) drug delivery via direct
fusion using detergent vesicle, (ii) induction of response on the cellular membrane via
designed vesicle, (iii) targeting of intracellular organelle using vesicle-in-vesicle, and
(iv) active targeting using antibody-displayed vesicle as case studies of the scheme.
In chapter 1, various kinds of surfactant vesicles were characteized, focusing
on the membrane properties that differ in their principle. The spontaneous aggregation
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of surfactants in an aqueous solution can induce the formation of lipid bilayer, resulting
in the unique properties (mem6rane properties) that are different from the properties of
sole molecule. The surfactant vesicles were quantitatively characteized in relation to
different kinds of membrane properties, such as "Jluidity", "flexibility", and "wetness".
It was found that the inner membrane properties of Span 80 vesicle, which was
composed by the non-ionic surfactant (sorbitan Monooleate; Span 80), were similar to
those of the POPC liposome composed by the phospholipid harboring a dipolar
structure at the hydrophilic head group. Both surfactant vesicles (Span 80 and POPC)
have headgroup and acyl chain structure and it is common that the inner phase of these
vesicles is composed by the similar acyl chain structure (unsaturated acyl chain). The
inner membrane properties of Span 80 vesicle are thus similar to those of the POPC
liposome in contrast to those of the DPPC liposome with saturated acyl chain. Both
Span 80 vesicle and POPC liposome have a membrane with liquid crystalline phase,
while DPPC liposome has a membrane with gel phase. The above character of the
membrane can herewith be regarded as "fluit' nature of the membrane. In addition, the
difference of the structure between Span 80 vesicle and POPC liposome also affected
the headgroup interaction, where the headgroup of POPC liposome interacts with each
other by the electrostatic interaction while that of Span 80 vesicle is composed by the
sorbitol structure to give a relatively weak interaction. By using the dielectric dispersion
analysis, the Span 80 vesicle was shown to have a dynamic membrane with high intense
headgroup mobility, which can be regarded as "flexible" nature. By using the
hydrophobicity-sensitive molecular probe (ANS), it was shown that the water molecule
could be easily inserted into the dynamic Span 80 vesicle membrane, which can be
regarded as "wet" nature. The membrane surface properties of surfactant vesicles, such
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as Span 80 vesicle and phospholipid vesicle, were thus characterized systematically
along with the different axis on "fluid')ooflexibleu, and*wet" riatures.
In chapter 2, the "membrane-membrane" interaction was evaluated by
investigating the membrane-related phenomena (i.e. calcein leakage and lipid mixing)
by using various surfactant vesicles characterized by the membrane properties. There
are three steps during the interaction between vesicles, perturbation, hemifusion, and
fusion which is the final step of the interaction of "ltetero"-vesicles. Span 80 vesicle
was found to aggregate (calcein leakage), and hemifuse (FRET method) with the
liposome. Although further investigation on the fusion between Span 80 vesicle and
liposome is needed (the aqueous content mixing assay), it is suggested that the
difference of membrane properties between vesicles ("membrane potentials") is the
important for the oomembrane-membrane" interaction. After the interaction with the
liposome, Span 80 vesicle was found to perturb the liposome membrane, resulting in the
induction of its hemifusion with the liposome membrane. These results suggest that the
surfactant vesicle with dpamic membrane surface is advantageous for the interaction
with the plasma membrane. After the interaction to the liposome membrane, Span 80
vesicle was found to diffrrse on the liposome membrane. Span 80 vesicle diffirsing on
the liposome membrane alters the liposome membrane more dynamic. The liposome
membrane hemifused with Span 80 vesicle was more "wet" as compared with the intact
liposome membrane. On the other hand, the dynamic membrane was disadvantageous
for the encapsulation of DOX.
The encapsulation effrciency of the DOX was employed by using remote
loading method. The existence of water molecule into the membrane ("wef'membrane)
was shown to prevent the insertion of DOX. It is therefore needed to design the
surfactant vesicle membrane with the high intense headgroup mobility and low
existence of water moiecule (e.c. Span 80' vesicle inserted choiesterol into the
membrane).
ln chapter 3, the design scheme for the novel surfactant vesicle to control the
membrane-membrane interaction was finally established based on the frndings
described in chapter 1 (i.e. membrane properties) and chapter 2 (i.e.
membrane-membrane interaction). It is suggested that this design scheme could also be
applicable for the plasma membrane (biological cells) because it partially consists of
phospholipid bilayer. It is generally known that the liposome is with less-interacting
nature with the plasma membrane, resulting in the inefficient drug datively to the cells.
If one could succeed in the enhancement of the liposome interaction with the plasma
membrane, the cellular-uptake of liposome through the endocytosis could incredibly be
promoted because one could employ the direct fusion strategy without the elimination
by exocytosis. The conventional strategy in drug delivery system, it is needed to
increase the intense of headgroup mobility according to the scheme of the drug carrier
design. Span 80 vesicle with high intense headgroup mobility was shown to fuse with
the plasma membrane, resulting in the diffirsion of Span 80 vesicle on the plasma
membrane. After the Span 80 interaction, the plasma membrane was found to become
the heterogeneous membrane, where different domains of phospholipids and Span 80
molecules could be formed on a same membrane. Considering the problems to be
solved in the conventional DDS design, the following case studies of the proposed
scheme were investigated. [1] Direct fusion via detergent vesicle: According this
scheme, headgroup mobility was shown to be an important key factor to the drug
delivery efficiency. The surfactant vesicle with low intense headgroup mobility was
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found to be uptaken by the endocytosis. On the other hand, the surfactant vesicle with
high intense headgroup mobility was shbwn to be uptaken by the membrane fusion,
resulting in the direct and effective drug delivery. [2] Induction of cellular membrane
response via designed vesicle: The alteration of the plasma membrane properties
prevent to the regulation of function on the membrane, resulting in the induction of
apoptotic like cell death (phosphatidylserine exposure). The plasma membrane
properties are important to control the membrane-relating functions, such as membrane
traffic or cellular signaling. It is therefore considered that the alteration of the plasma
membrane properties could induce some damages to the cells. As expected, the cells
were found to induce the cell death, accompanied with bleb-formation, by the treatment
of the cells with Span 80 vesicle. Moreover, this scheme was applied for the design of
complex drug delivery strategy, such as vesicle-in-vesicle system or modification of
protein on the surfactant membrane. [3] Targeting of intracellular organelle using
vesicle-in-vesicle: The vesicle-in-vesicle system is expected for the capability of the
organelle targeting drug delivery according the scheme of the drug carrier design. The
second inner vesicle is encapsulated into the first outside vesicle. The first outside
vesicle fuse with plasma membrane. The second irurer vesicle is released from the first
vesicle, delivering the drug to the organelle directly. In order to the design the drug
carrier based on the membrane properties according to the design scheme, it is
important to unchange the membrane properties of the surfactant vesicle. It was found
that the effective drug delivery could be carried out by using the vesicle-in-vesicle. [4]
Enhancement of DDS efficiency using antibody-displayed vesicle: It has been reported
the modification of the surfactant vesicle of substance (such as antibody) can improve
the its availability, especially, in relation to its delivery efficiency. However, the effect
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of modification for the membrane properties has been hardly investigated in the
previous reports. It is important to clarify the behavior of the substance modified on the
membrane of the surfactant vesicle to increase the binding activity for the plasma
membrane. It was shown that the suitable membrane to modifv the antibodv could
enhance the targeting of surfactant vesicle.
The scheme to control the "membrane-membrane" interaction based on the
"membrane properties" was thus established, by employing its possible application in
drug delivery system as a case study. It is expected that this research could contribute
the rational design of not only the drug carrier design, together with the deeper the
understanding of all phenomenon relating to the membrane.
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Suggesting for Future Work
1. Apptication of the membrane characterization for the surfactant vesicle
It is considered that all the surfactant vesicles have their individual membrane
properties, from phospholipid vesicle (liposome) to non-ionic surfactant vesicle
(niosome). In this thesis, these membrane properties were systematically categorized
along with "three" major categories, together with the analysis of "five" properties, (i)
inner membrane fluidity (DPH), (ii) membrane surface fluidity (TMA-DPH), (iii)
headgroup mobility (dielectric dispersion analysis), (iv) inner polarity (Laurdan), and
(v) membrane surface polarity (ANS). Various kinds of drug carriers have been
conventionally investigated since 1980's. In the previous investigation, these drug
carriers were evaluated, only focusing on the "phenomena", such as drug leakage,
retention time in the blood vessel, accumulation into the disease site, although the
evaluation of the function and nature of these drug carriers was only limited to
"case-by-case" trials. Therefore, these drug carriers have not been evaluated in a
systematic malrner. Howeveq this problem could be solved by the characterization of
the membrane of the drug carrier. These membrane properties, described here, can
contribute to the prognosis of the drug carrier behavior. As described in chapter 2,
"membrnne-membrane" interaction is well related with the membrane dynamics,
especially, the headgroup mobility of the surfactant vesicle membrane. The surfactant
vesicle with high-intense headgroup mobility easily inserts into and perfurbs the plasma
membrane. After the interaction with the membrane, the surfactant vesicle fuses with
the membrane. The fusing surfactant vesicle diffuses on the membrane, resulting in the
alteration of the membrane properties of the plasma membrane. On the other hand, the
surfactant vesicle with low-intense headgroup mobility interacted weakly with the
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plasma membrane as compared with that with high-intense headgroup mobility. This
surfactant vesicle does not perturb the plasma membrane, resulting in the uptake by
endocytosis pathway.
In this study, these characterizations of the surfactant vesicle membrane were
used for the design of the drug carrier. However, these membrane properties are
fundamental nature of the membrane, the characteization method can be also used for
other studies related to the membrane. It is expected that these knowledge is useful not
only the design of the drug carrier, but also the understanding of the phenomenon on the
membrane. For example, it is very difficult to analyze the protein behavior on the lipid
bilayer as compared with that in the solution. The membrane protein is related to
various cellular functions (such as signaling, membrane transfer, and uptake), while the
behavior of these membrane proteins has not been clarified. It has been already reported
that the plasma membrane can work as a "foothold" for the membrane protein,
especially on raft structure. Therefore the information of membrane properties
contributes to the clarification of the mechanism of the work of membrane proteins.
2. Induction of membrane-membrane interaction by the difference of membrane
properties
Membrane properties of the vesicle were shown to control the interaction with
the apposed vesicle. Vesicles were evaluated by various kinds of membrane properties
using fluorescence probes and dielectric dispersion analysis, as described above. The
membrane properties analysis by DPH (fluidity), dielectric dispersion analysis (flexible),
and polarity analysis by Laurdan (wet), respectively, show the membrane properties of
the headgroup region, boundary region, and acyl chain region, respectively. When the
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calcein leakage was evaluated, the increase of the difference of fluidity (Z l/P) and
flexibld ( Z lnfl) between Vesicles was shown io induce the perfurbbtion of the
membrane. Altematively, the decrease of the difference of wet (GPa+oi) induce the
perturbation of the membrane. Moreovea lipid mixing was also related with the
difference of the membrane properties between vesicles. Especially, the flexibility is
proportionality related with the %FT. tn this way, the concept of "Membrane Potential"
can be suitable for the explanation of the membrane-related phenomena. However, the
relationship between membrane properties and membrane-membrane interaction has not
been fully clarified yet in terms of molecule level. Further experiments are required to
refer the molar behavior irVon the membrane. The elucidation of the molar behavior
inlon the membrane is expected to improve the modulation of the self-assemble
properties itself and, also, membrane-membrane interaction in detail.
3. Design of the drug carri€r 
- 
rrlore complex drug delivery strategy -
In this study, the scheme of the drug carrier was established based on the
membrane properties described above. It has been reported that membrane fluidity is
important for the interaction of the vesicle on liposome membranes with the
biomembrane of the cells. However, it has been clarified that the headgroup mobility is
strongly related with the interaction with plasma membrane as shown in this scheme.
Moreover, the headgroup mobility was shown to be well correlated with the fusion
capacity. The fusion capacity can be applied for design of the complex drug delivery,
such as vesicle-in-vesicle system. Recently, the cause of various diseases has been
gradually clarified gradually, focusing on its relation with the intracellular organelles
that differ in the cellular function. It is thus necessary to deliver the drug to the each
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organelle, such as nuclear, golgi body, and mitochondria. The vesicle-in-vesicle system
is expected to contribute to fulfill these expectations relating to this issue.
Moreover, the membrane charactenzation is considered to control the behavior
of the surfactant vesicle modified with substance (such as antibody). It has been
reported that the modification of substance on the surfactant vesicle enhances the
accumulation of drug into the disease site, especially in the research area of cancer
chemotherapy. However, the use of these modified surfactant vesicles has a difficulty in
the complete inhibition of the tumor growth. In previous conventional reports by the
behavior of the substance on the surfactant vesicle membrane has not been investigated.
For example, it is important to expose the active site on the outer surface of the
surfactant vesicle in case of protein. When the active site can be hidden in the
membrane, the surfactant vesicle cannot be effectively bound to the cancer cells. The
protein can be deeply inserted into the surfactant vesicle membrane, especially in the
case of the membrane with high-intense headgroup mobility. The more headgroup
mobility is increased, the more the binding of protein can be inhibited by the membrane.
However, the reduction of the headgroup mobility of the surfactant vesicle prevents the
fusion with plasma membrane. This problem is solved by the strategy based on the
membrane properties. The heterogeneous membrane containing both membrane
properties is capable for the more effective drug delivery. The protein, modified on the
membrane with low fluidity, and the surfactant vesicle, which can interact with the
plasma membrane in the highly-fluid phase, should be selected for the design of the
high performance DDS.
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Nomenclature
: Membrane fluidity estimated by DPH or TMA-DPH
: Characteristic frequency at around 60 MHz (phospholipid),
and200 MHz (Span 80)
: General polarity into the surfactant vesicle membrane
: Ratio of the calcein fluorescence intensity (resolution from
self-quenching)
: Ratio of fluorescence resonance energy transfer
: material flow rate
: Concentration of the DOX in the outer phase
: Total surface area ofvesicle
: Total volume of vesicle
: Mass-transfercoefficient
: 50% inhibitory concentration
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List ofAbbreviation
ANS 8-Anilino-1-naphthalenesulfonic acid
Ch cholesterol
DDS Drug delivery System
DLS light scattering photometer
DMPC 1,2-dimirystoyl- sn-glycero-3-phosphocholine
DOX doxorubicin hvdrochloride
DPH 1,6-diphenyl-1,3,5-hexatriene
DPPC 1,2-dipalmitoyl-sn -glycero-3-phosphocholine
DSC differential scannins calorimeter
EGFR epidermal growth factor receptor
ERFR Fluorescence resonance energy transfer
ESA Eucheuma serra Agglutinin
GP generalized polarization
NBD_'E 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
(7 -nitr o -2 - I,3 -b enzoxadiazol- 4 -yl)
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